American National Group Inc 10-Q for FY2020 Q3
American National Group Inc. (ANG-PD)
10-Q
2020-11-06
For: 2020-09-30
View Original
Added on
April 06, 2026
About this 10-Q
American National Group Inc filed this 10-Q on November 6, 2020, covering the quarter ended September 30, 2020 (FY2020 Q3).
Headline figures
Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $798.71M
- up 24.1% from $643.4M a year earlier
- Net income
- $667.2M
- up 1685.9% from net income of $37.36M a year earlier
- Diluted EPS
- $7.17
- up 1648.8% from $0.41 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the quarterly period ended September 30, 2020
OR
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the transition period from ________ to ________
Commission File Number : 001-31911
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
(Address of principal executive offices, including zip code)
(515 ) 221-0002
(Registrant's telephone number, including area code)
Securities registered Pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
☒ | Accelerated filer | ☐ | |||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | |||||||||
| Emerging growth company | |||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
APPLICABLE TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:
As of October 30, 2020, there were 92,017,033 shares of the registrant's common stock, $1 par value, outstanding.
TABLE OF CONTENTS
| Page | |||||
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except share and per share data)
| September 30, 2020 | December 31, 2019 | ||||||||||
| (Unaudited) | |||||||||||
| Assets | |||||||||||
| Investments: | |||||||||||
Fixed maturity securities, available for sale, at fair value (amortized cost of $ | $ | $ | |||||||||
Mortgage loans on real estate (net of allowance for credit losses of $ | |||||||||||
| Derivative instruments | |||||||||||
| Other investments | |||||||||||
| Total investments | |||||||||||
| Cash and cash equivalents | |||||||||||
Coinsurance deposits (net of allowance for credit losses of $ | |||||||||||
| Accrued investment income | |||||||||||
| Deferred policy acquisition costs | |||||||||||
| Deferred sales inducements | |||||||||||
| Income taxes recoverable | |||||||||||
| Other assets | |||||||||||
| Total assets | $ | $ | |||||||||
| Liabilities and Stockholders' Equity | |||||||||||
| Liabilities: | |||||||||||
| Policy benefit reserves | $ | $ | |||||||||
| Other policy funds and contract claims | |||||||||||
| Notes payable | |||||||||||
| Subordinated debentures | |||||||||||
| Deferred income taxes | |||||||||||
| Income taxes payable | |||||||||||
| Other liabilities | |||||||||||
| Total liabilities | |||||||||||
| Stockholders' equity: | |||||||||||
Preferred stock, Series A; par value $ 2020 - 2019 - | |||||||||||
Preferred stock, Series B; par value $ 2020 - 2019 - | |||||||||||
Common stock; par value $ 2020 - 2019 - | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated other comprehensive income | |||||||||||
| Retained earnings | |||||||||||
| Total stockholders' equity | |||||||||||
| Total liabilities and stockholders' equity | $ | $ | |||||||||
See accompanying notes to unaudited consolidated financial statements.
2
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in thousands, except per share data)
(Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| Revenues: | |||||||||||||||||||||||
| Premiums and other considerations | $ | $ | $ | $ | |||||||||||||||||||
| Annuity product charges | |||||||||||||||||||||||
| Net investment income | |||||||||||||||||||||||
| Change in fair value of derivatives | ( | ( | |||||||||||||||||||||
Net realized gains (losses) on investments | ( | ( | ( | ||||||||||||||||||||
| Other than temporary impairment (OTTI) losses on investments: | |||||||||||||||||||||||
| Total OTTI losses | ( | ( | |||||||||||||||||||||
| Portion of OTTI losses recognized from other comprehensive income | ( | ||||||||||||||||||||||
| Net OTTI losses recognized in operations | ( | ( | |||||||||||||||||||||
| Loss on extinguishment of debt | ( | ||||||||||||||||||||||
| Total revenues | |||||||||||||||||||||||
| Benefits and expenses: | |||||||||||||||||||||||
| Insurance policy benefits and change in future policy benefits | |||||||||||||||||||||||
| Interest sensitive and index product benefits | |||||||||||||||||||||||
| Amortization of deferred sales inducements | ( | ( | |||||||||||||||||||||
| Change in fair value of embedded derivatives | ( | ( | |||||||||||||||||||||
| Interest expense on notes payable | |||||||||||||||||||||||
| Interest expense on subordinated debentures | |||||||||||||||||||||||
| Amortization of deferred policy acquisition costs | ( | ( | |||||||||||||||||||||
| Other operating costs and expenses | |||||||||||||||||||||||
| Total benefits and expenses | ( | ||||||||||||||||||||||
| Income before income taxes | |||||||||||||||||||||||
| Income tax expense | |||||||||||||||||||||||
| Net income | |||||||||||||||||||||||
| Less: Preferred stock dividends | |||||||||||||||||||||||
| Net income available to common stockholders | $ | $ | $ | $ | |||||||||||||||||||
| Earnings per common share | $ | $ | $ | $ | |||||||||||||||||||
| Earnings per common share - assuming dilution | $ | $ | $ | $ | |||||||||||||||||||
| Weighted average common shares outstanding (in thousands): | |||||||||||||||||||||||
| Earnings per common share | |||||||||||||||||||||||
| Earnings per common share - assuming dilution | |||||||||||||||||||||||
See accompanying notes to unaudited consolidated financial statements.
3
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Dollars in thousands)
(Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| Net income | $ | $ | $ | $ | |||||||||||||||||||
| Other comprehensive income: | |||||||||||||||||||||||
| Change in net unrealized investment gains/losses (1) | |||||||||||||||||||||||
| Noncredit component of OTTI losses (1) | |||||||||||||||||||||||
| Reclassification of unrealized investment gains/losses to net income (1) | |||||||||||||||||||||||
| Other comprehensive income before income tax | |||||||||||||||||||||||
| Income tax effect related to other comprehensive income | ( | ( | ( | ( | |||||||||||||||||||
| Other comprehensive income | |||||||||||||||||||||||
| Comprehensive income | $ | $ | $ | $ | |||||||||||||||||||
(1)Net of related adjustments to amortization of deferred sales inducements and deferred policy acquisition costs.
See accompanying notes to unaudited consolidated financial statements.
4
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
(Dollars in thousands, except share data)
(Unaudited)
| Preferred Stock | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income | Retained Earnings | Total Stockholders' Equity | ||||||||||||||||||||||||||||||
| For the nine months ended September 30, 2020 | |||||||||||||||||||||||||||||||||||
| Balance at December 31, 2019 | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Net income for period | — | — | — | — | |||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | |||||||||||||||||||||||||||||||
Issuance of preferred stock | — | — | — | ||||||||||||||||||||||||||||||||
Share-based compensation | — | — | — | — | |||||||||||||||||||||||||||||||
Issuance of | — | — | — | ||||||||||||||||||||||||||||||||
Cumulative effect of change in accounting principle | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||
| Dividends on preferred stock | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||
| Balance at September 30, 2020 | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Preferred Stock | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income | Retained Earnings | Total Stockholders' Equity | ||||||||||||||||||||||||||||||
| For the three months ended September 30, 2020 | |||||||||||||||||||||||||||||||||||
| Balance at June 30, 2020 | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Net income for period | — | — | — | — | |||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | |||||||||||||||||||||||||||||||
| Share-based compensation | — | — | — | — | |||||||||||||||||||||||||||||||
Issuance of | — | ( | — | — | |||||||||||||||||||||||||||||||
| Dividends on preferred stock | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||
| Balance at September 30, 2020 | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Preferred Stock | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income (Loss) | Retained Earnings | Total Stockholders' Equity | ||||||||||||||||||||||||||||||
| For the nine months ended September 30, 2019 | |||||||||||||||||||||||||||||||||||
| Balance at December 31, 2018 | $ | $ | $ | $ | ( | $ | $ | ||||||||||||||||||||||||||||
| Net income for period | — | — | — | — | |||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | |||||||||||||||||||||||||||||||
Share-based compensation | — | — | — | — | |||||||||||||||||||||||||||||||
Issuance of | — | ( | — | — | |||||||||||||||||||||||||||||||
| Balance at September 30, 2019 | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Preferred Stock | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income | Retained Earnings | Total Stockholders' Equity | ||||||||||||||||||||||||||||||
| For the three months ended September 30, 2019 | |||||||||||||||||||||||||||||||||||
| Balance at June 30, 2019 | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Net income for period | — | — | — | — | |||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | |||||||||||||||||||||||||||||||
| Share-based compensation | — | — | — | — | |||||||||||||||||||||||||||||||
Issuance of | — | — | — | ||||||||||||||||||||||||||||||||
| Balance at September 30, 2019 | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
See accompanying notes to unaudited consolidated financial statements.
5
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in thousands)
(Unaudited)
| Nine Months Ended September 30, | |||||||||||
| 2020 | 2019 | ||||||||||
| Operating activities | |||||||||||
| Net income | $ | $ | |||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Interest sensitive and index product benefits | |||||||||||
| Amortization of deferred sales inducements | ( | ||||||||||
| Annuity product charges | ( | ( | |||||||||
| Change in fair value of embedded derivatives | ( | ||||||||||
| Change in traditional life and accident and health insurance reserves | ( | ||||||||||
| Policy acquisition costs deferred | ( | ( | |||||||||
| Amortization of deferred policy acquisition costs | ( | ||||||||||
| Provision for depreciation and other amortization | |||||||||||
| Amortization of discounts and premiums on investments | |||||||||||
| Realized gains/losses on investments | |||||||||||
| Distributions from equity method investments | |||||||||||
| Change in fair value of derivatives | ( | ||||||||||
| Deferred income taxes | ( | ||||||||||
| Loss on extinguishment of debt | |||||||||||
| Share-based compensation | |||||||||||
| Change in accrued investment income | ( | ||||||||||
| Change in income taxes recoverable/payable | ( | ( | |||||||||
| Change in other assets | ( | ||||||||||
| Change in other policy funds and contract claims | ( | ( | |||||||||
| Change in collateral held for derivatives | ( | ||||||||||
| Change in collateral held for securities lending | ( | ||||||||||
| Change in other liabilities | ( | ||||||||||
| Other | ( | ||||||||||
| Net cash provided by operating activities | |||||||||||
| Investing activities | |||||||||||
| Sales, maturities, or repayments of investments: | |||||||||||
| Fixed maturity securities, available for sale | |||||||||||
| Mortgage loans on real estate | |||||||||||
| Derivative instruments | |||||||||||
| Other investments | |||||||||||
| Acquisitions of investments: | |||||||||||
| Fixed maturity securities, available for sale | ( | ( | |||||||||
| Mortgage loans on real estate | ( | ( | |||||||||
| Derivative instruments | ( | ( | |||||||||
| Other investments | ( | ( | |||||||||
| Purchases of property, furniture and equipment | ( | ( | |||||||||
| Net cash provided by (used in) investing activities | ( | ||||||||||
6
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
(Dollars in thousands)
(Unaudited)
| Nine Months Ended September 30, | |||||||||||
| 2020 | 2019 | ||||||||||
| Financing activities | |||||||||||
| Receipts credited to annuity policyholder account balances | $ | $ | |||||||||
| Coinsurance deposits | |||||||||||
| Return of annuity policyholder account balances | ( | ( | |||||||||
| Repayment of subordinated debentures | ( | ||||||||||
| Net proceeds from amounts due under repurchase agreements | ( | ||||||||||
| Proceeds from issuance of preferred stock, net | |||||||||||
| Proceeds from issuance of common stock, net | |||||||||||
| Change in checks in excess of cash balance | ( | ( | |||||||||
| Preferred stock dividends | ( | ||||||||||
| Net cash provided by (used in) financing activities | ( | ||||||||||
| Increase in cash and cash equivalents | |||||||||||
| Cash and cash equivalents at beginning of period | |||||||||||
| Cash and cash equivalents at end of period | $ | $ | |||||||||
| Supplemental disclosures of cash flow information | |||||||||||
| Cash paid during period for: | |||||||||||
| Interest expense | $ | $ | |||||||||
| Income taxes | |||||||||||
| Non-cash operating activity: | |||||||||||
| Deferral of sales inducements | |||||||||||
See accompanying notes to unaudited consolidated financial statements.
7
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2020
(Unaudited)
1. Significant Accounting Policies
Consolidation and Basis of Presentation
The accompanying consolidated financial statements of American Equity Investment Life Holding Company ("we", "us", "our" or the "Company") have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and notes required by GAAP for complete financial statements. The consolidated financial statements reflect all adjustments, consisting only of normal recurring items, which are necessary to present fairly our financial position and results of operations on a basis consistent with the prior audited consolidated financial statements. Operating results for the three and nine month periods ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ended December 31, 2020. All significant intercompany accounts and transactions have been eliminated. The preparation of financial statements requires the use of management estimates. For further information related to a description of areas of judgment and estimates and other information necessary to understand our financial position and results of operations, refer to the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December 31, 2019.
Adopted Accounting Pronouncements
In June 2016, the Financial Accounting Standards Board (“FASB”) issued an accounting standards update (“ASU”) that significantly changed the impairment model for most financial assets that are measured at amortized cost and certain other instruments from an incurred loss model to an expected loss model that requires these assets be presented at the net amount expected to be collected. In addition, credit losses on available for sale debt securities will be recorded through an allowance account subsequent to the adoption of this ASU. We adopted this ASU on January 1, 2020. The adoption of this ASU resulted in an increase in our mortgage loan allowance for credit losses of $8.6 million and the recognition of an allowance for credit losses on our reinsurance recoverable/coinsurance deposits balances of $3.2 million on the date of adoption. Retained earnings was decreased by $9.3 million, which reflects the net of tax impact of the increase in the mortgage loan allowance for credit losses and the recognition of an allowance for credit losses on our reinsurance recoverable/coinsurance deposits balances on the date of adoption.
New Accounting Pronouncements
In August 2018, the FASB issued an ASU that revises certain aspects of the measurement models and disclosure requirements for long duration insurance and investment contracts. The FASB’s objective in issuing this ASU is to improve, simplify, and enhance the accounting for long-duration contracts. The revisions include updating cash flow assumptions in the calculation of the liability for traditional life products, introducing the term ‘market risk benefit’ ("MRB") and requiring all contract features meeting the definition of an MRB to be measured at fair value, simplifying the method used to amortize deferred policy acquisition costs and deferred sales inducements to a constant basis over the expected term of the related contracts rather than based on actual and estimated gross profits and enhancing disclosure requirements. While this ASU is effective for us on January 1, 2023, the transition date (the remeasurement date) is January 1, 2021. Early adoption of this ASU is permitted. We are in the process of evaluating the impact this guidance will have on our consolidated financial statements.
8
2. Fair Values of Financial Instruments
The following sets forth a comparison of the carrying amounts and fair values of our financial instruments:
| September 30, 2020 | December 31, 2019 | ||||||||||||||||||||||
| Carrying Amount | Fair Value | Carrying Amount | Fair Value | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Fixed maturity securities, available for sale | $ | $ | $ | $ | |||||||||||||||||||
| Mortgage loans on real estate | |||||||||||||||||||||||
| Derivative instruments | |||||||||||||||||||||||
| Other investments | |||||||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||||||
| Coinsurance deposits | |||||||||||||||||||||||
| Interest rate caps | |||||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Policy benefit reserves | |||||||||||||||||||||||
| Single premium immediate annuity (SPIA) benefit reserves | |||||||||||||||||||||||
| Notes payable | |||||||||||||||||||||||
| Subordinated debentures | |||||||||||||||||||||||
Fair value is the price that would be received to sell an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. The objective of a fair value measurement is to determine that price for each financial instrument at each measurement date. We meet this objective using various methods of valuation that include market, income and cost approaches.
We categorize our financial instruments into three levels of fair value hierarchy based on the priority of inputs used in determining fair value. The hierarchy defines the highest priority inputs (Level 1) as quoted prices in active markets for identical assets or liabilities. The lowest priority inputs (Level 3) are our own assumptions about what a market participant would use in determining fair value such as estimated future cash flows. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, a financial instrument's level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. We categorize financial assets and liabilities recorded at fair value in the consolidated balance sheets as follows:
Level 1 - Quoted prices are available in active markets for identical financial instruments as of the reporting date. We do not adjust the quoted price for these financial instruments, even in situations where we hold a large position and a sale could reasonably impact the quoted price.
Level 2 - Quoted prices in active markets for similar financial instruments, quoted prices for identical or similar financial instruments in markets that are not active; and models and other valuation methodologies using inputs other than quoted prices that are observable.
Level 3 - Models and other valuation methodologies using significant inputs that are unobservable for financial instruments and include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in Level 3 are securities for which no market activity or data exists and for which we used discounted expected future cash flows with our own assumptions about what a market participant would use in determining fair value.
9
Our assets and liabilities which are measured at fair value on a recurring basis as of September 30, 2020 and December 31, 2019 are presented below based on the fair value hierarchy levels:
| Total Fair Value | Quoted Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| September 30, 2020 | |||||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Fixed maturity securities, available for sale: | |||||||||||||||||||||||
| United States Government full faith and credit | $ | $ | $ | $ | |||||||||||||||||||
| United States Government sponsored agencies | |||||||||||||||||||||||
| United States municipalities, states and territories | |||||||||||||||||||||||
| Foreign government obligations | |||||||||||||||||||||||
| Corporate securities | |||||||||||||||||||||||
| Residential mortgage backed securities | |||||||||||||||||||||||
| Commercial mortgage backed securities | |||||||||||||||||||||||
| Other asset backed securities | |||||||||||||||||||||||
| Derivative instruments | |||||||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||||||
| $ | $ | $ | $ | ||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Fixed index annuities - embedded derivatives | $ | $ | $ | $ | |||||||||||||||||||
| December 31, 2019 | |||||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Fixed maturity securities, available for sale: | |||||||||||||||||||||||
| United States Government full faith and credit | $ | $ | $ | $ | |||||||||||||||||||
| United States Government sponsored agencies | |||||||||||||||||||||||
| United States municipalities, states and territories | |||||||||||||||||||||||
| Foreign government obligations | |||||||||||||||||||||||
| Corporate securities | |||||||||||||||||||||||
| Residential mortgage backed securities | |||||||||||||||||||||||
| Commercial mortgage backed securities | |||||||||||||||||||||||
| Other asset backed securities | |||||||||||||||||||||||
| Derivative instruments | |||||||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||||||
| Interest rate caps | |||||||||||||||||||||||
| $ | $ | $ | $ | ||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Fixed index annuities - embedded derivatives | $ | $ | $ | $ | |||||||||||||||||||
The following methods and assumptions were used in estimating the fair values of financial instruments during the periods presented in these consolidated financial statements.
Fixed maturity securities
The fair values of fixed maturity securities in an active and orderly market are determined by utilizing independent pricing services. The independent pricing services incorporate a variety of observable market data in their valuation techniques, including:
•reported trading prices,
•benchmark yields,
•broker-dealer quotes,
•benchmark securities,
•bids and offers,
•credit ratings,
•relative credit information, and
•other reference data.
10
The independent pricing services also take in to account perceived market movements and sector news, as well as a security's terms and conditions, including any features specific to that issue that may influence risk and marketability. Depending on the security, the priority of the use of observable market inputs may change as some observable market inputs may not be relevant or additional inputs may be necessary.
The independent pricing services provide quoted market prices when available. Quoted prices are not always available due to market inactivity. When quoted market prices are not available, the third parties use yield data and other factors relating to instruments or securities with similar characteristics to determine fair value for securities that are not actively traded. We generally obtain one value from our primary external pricing service. In situations where a price is not available from this service, we may obtain quotes or prices from additional parties as needed. Market indices of similar rated asset class spreads are considered for valuations and broker indications of similar securities are compared. Inputs used by the broker include market information, such as yield data and other factors relating to instruments or securities with similar characteristics. Valuations and quotes obtained from third party commercial pricing services are non-binding and do not represent quotes on which one may execute the disposition of the assets.
We validate external valuations at least quarterly through a combination of procedures that include the evaluation of methodologies used by the pricing services, comparison of the prices to a secondary pricing source, analytical reviews and performance analysis of the prices against trends, and maintenance of a securities watch list. Additionally, as needed we utilize discounted cash flow models or perform independent valuations on a case-by-case basis using inputs and assumptions similar to those used by the pricing services. Although we do identify differences from time to time as a result of these validation procedures, we did not make any significant adjustments as of September 30, 2020 and December 31, 2019.
Mortgage loans on real estate
Mortgage loans on real estate are not measured at fair value on a recurring basis. The fair values of mortgage loans on real estate are calculated using discounted expected cash flows using competitive market interest rates currently being offered for similar loans. The fair values of impaired mortgage loans on real estate that we have considered to be collateral dependent are based on the fair value of the real estate collateral (based on appraised values) less estimated costs to sell. The inputs utilized to determine fair value of all mortgage loans are unobservable market data (competitive market interest rates); therefore, fair value of mortgage loans falls into Level 3 in the fair value hierarchy.
Derivative instruments
The fair values of derivative instruments, primarily call options, are based upon the amount of cash that we will receive to settle each derivative instrument on the reporting date. These amounts are determined by our investment team using industry accepted valuation models and are adjusted for the nonperformance risk of each counterparty net of any collateral held. Inputs include market volatility and risk free interest rates and are used in income valuation techniques in arriving at a fair value for each option contract. The nonperformance risk for each counterparty is based upon its credit default swap rate. We have no performance obligations related to the call options purchased to fund our fixed index annuity policy liabilities.
Other investments
Financial instruments included in other investments that are not measured at fair value on a recurring basis are policy loans, equity method investments and company owned life insurance ("COLI"). We have not attempted to determine the fair values associated with our policy loans, as we believe any differences between carrying values and the fair values afforded these instruments are immaterial to our consolidated financial position and, accordingly, the cost to provide such disclosure does not justify the benefit to be derived. The fair values of our equity method investments are obtained from third parties and are determined using a variety of valuation techniques, including discounted cash flow analysis, valuation multiples analysis for comparable investments and appraisal values. As the risk spread and liquidity discount are unobservable market inputs, the fair value of our equity method investments falls within Level 3 of the fair value hierarchy. The fair value of our COLI approximates the cash surrender value of the policies and falls within Level 2 of the fair value hierarchy.
Cash and cash equivalents
Amounts reported in the consolidated balance sheets for these instruments are reported at their historical cost which approximates fair value due to the nature of the assets assigned to this category.
Interest rate caps
The fair values of our interest rate caps are obtained from third parties and are determined by discounting expected future cash flows using a projected London Interbank Offered Rate ("LIBOR") for the term of the caps.
11
Policy benefit reserves, coinsurance deposits and SPIA benefit reserves
The fair values of the liabilities under contracts not involving significant mortality or morbidity risks (principally deferred annuities), are stated at the cost we would incur to extinguish the liability (i.e., the cash surrender value) as these contracts are generally issued without an annuitization date. The coinsurance deposits related to the annuity benefit reserves have fair values determined in a similar fashion. For period-certain annuity benefit contracts, the fair value is determined by discounting the benefits at the interest rates currently in effect for newly issued immediate annuity contracts. We are not required to and have not estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value. Policy benefit reserves, coinsurance deposits and SPIA benefit reserves are not measured at fair value on a recurring basis. All of the fair values presented within these categories fall within Level 3 of the fair value hierarchy as most of the inputs are unobservable market data.
Notes payable
The fair values of our senior unsecured notes are based upon quoted market prices and are categorized as Level 2 within the fair value hierarchy. Notes payable are not remeasured at fair value on a recurring basis.
Subordinated debentures
Fair values for subordinated debentures are estimated using discounted cash flow calculations based principally on observable inputs including our incremental borrowing rates, which reflect our credit rating, for similar types of borrowings with maturities consistent with those remaining for the debt being valued. These fair values are categorized as Level 2 within the fair value hierarchy. Subordinated debentures are not measured at fair value on a recurring basis.
Fixed index annuities - embedded derivatives
We estimate the fair value of the embedded derivative component of our fixed index annuity policy benefit reserves at each valuation date by (i) projecting policy contract values and minimum guaranteed contract values over the expected lives of the contracts and (ii) discounting the excess of the projected contract value amounts at the applicable risk free interest rates adjusted for our nonperformance risk related to those liabilities. The projections of policy contract values are based on our best estimate assumptions for future policy growth and future policy decrements. Our best estimate assumptions for future policy growth include assumptions for the expected index credit on the next policy anniversary date which are derived from the fair values of the underlying call options purchased to fund such index credits and the expected costs of annual call options we will purchase in the future to fund index credits beyond the next policy anniversary. The projections of minimum guaranteed contract values include the same best estimate assumptions for policy decrements as were used to project policy contract values.
Within this determination we have the following significant unobservable inputs: 1) the expected cost of annual call options we will purchase in the future to fund index credits beyond the next policy anniversary and 2) our best estimates for future policy decrements, primarily lapse, partial withdrawal and mortality rates. As of September 30, 2020 and December 31, 2019, we utilized an estimate of 2.10 % and 2.90 %, respectively, for the expected cost of annual call options, which is based on estimated long-term account value growth and a historical review of our actual option costs. The decrease in the expected cost of annual call options was due to an update in our estimated long-term account value growth as a result of current economic conditions and the low interest rate environment.
Our best estimate assumptions for lapse, partial withdrawal and mortality rates are based on our actual experience and our outlook as to future expectations for such assumptions. These assumptions, which are consistent with the assumptions used in calculating deferred policy acquisition costs and deferred sales inducements, are reviewed on a quarterly basis and are revised as our experience develops and/or as future expectations change. The following table presents average lapse rate and partial withdrawal rate assumptions, by contract duration, used in estimating the fair value of the embedded derivative component of our fixed index annuity policy benefit reserves at each reporting date:
| Average Lapse Rates | Average Partial Withdrawal Rates | |||||||||||||||||||||||||
| Contract Duration (Years) | September 30, 2020 | December 31, 2019 | September 30, 2020 | December 31, 2019 | ||||||||||||||||||||||
Lapse rates are generally expected to increase as surrender charge percentages decrease. Lapse expectations reflect a significant increase in the year in which the surrender charge period on a contract ends.
12
The following table provides a reconciliation of the beginning and ending balances for our Level 3 liabilities, which are measured at fair value on a recurring basis using significant unobservable inputs for the three and nine months ended September 30, 2020 and 2019:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Fixed index annuities - embedded derivatives | |||||||||||||||||||||||
| Beginning balance | $ | $ | $ | $ | |||||||||||||||||||
| Premiums less benefits | |||||||||||||||||||||||
| Change in fair value, net | ( | ( | |||||||||||||||||||||
| Ending balance | $ | $ | $ | $ | |||||||||||||||||||
The fair value of our fixed index annuities embedded derivatives is net of coinsurance ceded of $611.2 million and $644.6 million as of September 30, 2020 and December 31, 2019, respectively. Change in fair value, net for each period in our embedded derivatives is included in change in fair value of embedded derivatives in the unaudited consolidated statements of operations.
Certain derivatives embedded in our fixed index annuity contracts are our most significant financial instrument measured at fair value that are categorized as Level 3 in the fair value hierarchy. The contractual obligations for future annual index credits within our fixed index annuity contracts are treated as a "series of embedded derivatives" over the expected life of the applicable contracts. We estimate the fair value of these embedded derivatives at each valuation date by the method described above under fixed index annuities - embedded derivatives. The projections of minimum guaranteed contract values include the same best estimate assumptions for policy decrements as were used to project policy contract values.
13
3. Investments
At September 30, 2020 and December 31, 2019, the amortized cost and fair value of fixed maturity securities were as follows:
| Amortized Cost (1) | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Fair Value | |||||||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||||||||
| September 30, 2020 | |||||||||||||||||||||||||||||
| Fixed maturity securities, available for sale: | |||||||||||||||||||||||||||||
| United States Government full faith and credit | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| United States Government sponsored agencies | ( | ||||||||||||||||||||||||||||
| United States municipalities, states and territories | ( | ||||||||||||||||||||||||||||
| Foreign government obligations | ( | ||||||||||||||||||||||||||||
| Corporate securities | ( | ( | |||||||||||||||||||||||||||
| Residential mortgage backed securities | ( | ( | |||||||||||||||||||||||||||
| Commercial mortgage backed securities | ( | ( | |||||||||||||||||||||||||||
| Other asset backed securities | ( | ||||||||||||||||||||||||||||
| $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||
| December 31, 2019 | |||||||||||||||||||||||||||||
| Fixed maturity securities, available for sale: | |||||||||||||||||||||||||||||
| United States Government full faith and credit | $ | $ | $ | ( | $ | — | $ | ||||||||||||||||||||||
| United States Government sponsored agencies | ( | — | |||||||||||||||||||||||||||
| United States municipalities, states and territories | ( | — | |||||||||||||||||||||||||||
| Foreign government obligations | — | ||||||||||||||||||||||||||||
| Corporate securities | ( | — | |||||||||||||||||||||||||||
| Residential mortgage backed securities | ( | — | |||||||||||||||||||||||||||
| Commercial mortgage backed securities | ( | — | |||||||||||||||||||||||||||
| Other asset backed securities | ( | — | |||||||||||||||||||||||||||
| $ | $ | $ | ( | $ | — | $ | |||||||||||||||||||||||
The amortized cost and fair value of fixed maturity securities at September 30, 2020, by contractual maturity are shown below. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. All of our mortgage and other asset backed securities provide for periodic payments throughout their lives and are shown below as separate lines.
| Available for sale | |||||||||||
| Amortized Cost | Fair Value | ||||||||||
| (Dollars in thousands) | |||||||||||
| Due in one year or less | $ | $ | |||||||||
| Due after one year through five years | |||||||||||
| Due after five years through ten years | |||||||||||
| Due after ten years through twenty years | |||||||||||
| Due after twenty years | |||||||||||
| Residential mortgage backed securities | |||||||||||
| Commercial mortgage backed securities | |||||||||||
| Other asset backed securities | |||||||||||
| $ | $ | ||||||||||
14
Net unrealized gains on available for sale fixed maturity securities reported as a separate component of stockholders' equity were comprised of the following:
| September 30, 2020 | December 31, 2019 | ||||||||||
| (Dollars in thousands) | |||||||||||
| Net unrealized gains on available for sale fixed maturity securities | $ | $ | |||||||||
| Adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements | ( | ( | |||||||||
| Deferred income tax valuation allowance reversal | |||||||||||
| Deferred income tax expense | ( | ( | |||||||||
| Net unrealized gains reported as accumulated other comprehensive income | $ | $ | |||||||||
The National Association of Insurance Commissioners ("NAIC") assigns designations to fixed maturity securities. These designations range from Class 1 (highest quality) to Class 6 (lowest quality). In general, securities are assigned a designation based upon the ratings they are given by the Nationally Recognized Statistical Rating Organizations ("NRSRO’s"). The NAIC designations are utilized by insurers in preparing their annual statutory statements. NAIC Class 1 and 2 designations are considered "investment grade" while NAIC Class 3 through 6 designations are considered "non-investment grade." Based on the NAIC designations, we had 96 % and 98 % of our fixed maturity portfolio rated investment grade at September 30, 2020 and December 31, 2019, respectively.
The following table summarizes the credit quality, as determined by NAIC designation, of our fixed maturity portfolio as of the dates indicated:
| September 30, 2020 | December 31, 2019 | |||||||||||||||||||||||||
| NAIC Designation | Amortized Cost | Fair Value | Amortized Cost | Fair Value | ||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||
| 1 | $ | $ | $ | $ | ||||||||||||||||||||||
| 2 | ||||||||||||||||||||||||||
| 3 | ||||||||||||||||||||||||||
| 4 | ||||||||||||||||||||||||||
| 5 | ||||||||||||||||||||||||||
| 6 | ||||||||||||||||||||||||||
| $ | $ | $ | $ | |||||||||||||||||||||||
15
The following table shows our investments' gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities (consisting of 1,344 and 1,033 securities, respectively) have been in a continuous unrealized loss position, at September 30, 2020 and December 31, 2019:
| Less than 12 months | 12 months or more | Total | |||||||||||||||||||||||||||||||||
| Fair Value | Unrealized Losses (1) | Fair Value | Unrealized Losses (1) | Fair Value | Unrealized Losses (1) | ||||||||||||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||||||||||||||
| September 30, 2020 | |||||||||||||||||||||||||||||||||||
| Fixed maturity securities, available for sale: | |||||||||||||||||||||||||||||||||||
| United States Government sponsored agencies | $ | $ | ( | $ | $ | $ | $ | ( | |||||||||||||||||||||||||||
| United States municipalities, states and territories | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Foreign government obligations | ( | ( | |||||||||||||||||||||||||||||||||
| Corporate securities: | |||||||||||||||||||||||||||||||||||
| Finance, insurance and real estate | ( | ( | |||||||||||||||||||||||||||||||||
| Manufacturing, construction and mining | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Utilities and related sectors | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Wholesale/retail trade | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Services, media and other | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Residential mortgage backed securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Commercial mortgage backed securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Other asset backed securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
| $ | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||||||||||||||||||||
| December 31, 2019 | |||||||||||||||||||||||||||||||||||
| Fixed maturity securities, available for sale: | |||||||||||||||||||||||||||||||||||
| United States Government full faith and credit | $ | $ | ( | $ | $ | $ | $ | ( | |||||||||||||||||||||||||||
| United States Government sponsored agencies | ( | ( | ( | ||||||||||||||||||||||||||||||||
| United States municipalities, states and territories | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Corporate securities: | |||||||||||||||||||||||||||||||||||
| Finance, insurance and real estate | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Manufacturing, construction and mining | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Utilities and related sectors | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Wholesale/retail trade | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Services, media and other | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Residential mortgage backed securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Commercial mortgage backed securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Other asset backed securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
| $ | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||||||||||||||||||||
The unrealized losses at September 30, 2020 are principally related to the impacts the COVID-19 pandemic had on credit markets. In addition, certain unrealized losses at September 30, 2020 are related to the timing of the purchases of certain securities, which carry less yield than those currently available. Approximately 67 % and 79 % of the unrealized losses on fixed maturity securities shown in the above table for September 30, 2020 and December 31, 2019, respectively, are on securities that are rated investment grade, defined as being the highest two NAIC designations.
We expect to recover our amortized cost on all securities except for those securities on which we recognized an allowance for credit loss. In addition, because we did not have the intent to sell fixed maturity securities with unrealized losses and it was not more likely than not that we would be required to sell these securities prior to recovery of the amortized cost, which may be maturity, we did not write down these investments to fair value through operations.
16
Changes in net unrealized gains/losses on investments for the three and nine months ended September 30, 2020 and 2019 are as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Fixed maturity securities available for sale carried at fair value | $ | $ | $ | $ | |||||||||||||||||||
| Adjustment for effect on other balance sheet accounts: | |||||||||||||||||||||||
| Deferred policy acquisition costs and deferred sales inducements | ( | ( | ( | ( | |||||||||||||||||||
| Deferred income tax asset/liability | ( | ( | ( | ( | |||||||||||||||||||
| ( | ( | ( | ( | ||||||||||||||||||||
| Change in net unrealized gains/losses on investments carried at fair value | $ | $ | $ | $ | |||||||||||||||||||
Proceeds from sales of available for sale fixed maturity securities for the nine months ended September 30, 2020 and 2019 were $1.1 billion and $707.5 million, respectively. Scheduled principal repayments, calls and tenders for available for sale fixed maturity securities for the nine months ended September 30, 2020 and 2019 were $2.3 billion and $1.5 billion, respectively.
Net realized gains (losses) on investments for the three and nine months ended September 30, 2020 and 2019, are as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Available for sale fixed maturity securities: | |||||||||||||||||||||||
| Gross realized gains | $ | $ | $ | $ | |||||||||||||||||||
| Gross realized losses | ( | ( | ( | ( | |||||||||||||||||||
| Credit losses (1) | ( | ( | |||||||||||||||||||||
| ( | ( | ||||||||||||||||||||||
| Other investments: | |||||||||||||||||||||||
| Gross realized gains | |||||||||||||||||||||||
| Gross realized losses | ( | ||||||||||||||||||||||
| ( | |||||||||||||||||||||||
| Mortgage loans on real estate: | |||||||||||||||||||||||
| Increase (decrease) in allowance for credit losses | ( | ( | |||||||||||||||||||||
| Recovery of specific allowance | |||||||||||||||||||||||
| ( | ( | ||||||||||||||||||||||
| $ | ( | $ | $ | ( | $ | ( | |||||||||||||||||
Realized losses on available for sale fixed maturity securities in 2020 and 2019 were realized primarily due to strategies to reposition the fixed maturity security portfolio that result in improved net investment income, credit risk or duration profiles as they pertain to our asset liability management. Realized gains and losses on sales are determined on the basis of specific identification of investments based on the trade date.
17
We have a policy and process to identify securities that could potentially have credit loss. This process involves monitoring market events and other items that could impact issuers. The evaluation includes but is not limited to such factors as:
•the extent to which the fair value has been less than amortized cost or cost;
•whether the issuer is current on all payments and all contractual payments have been made as agreed;
•the remaining payment terms and the financial condition and near-term prospects of the issuer;
•the lack of ability to refinance due to liquidity problems in the credit market;
•the fair value of any underlying collateral;
•the existence of any credit protection available;
•our intent to sell and whether it is more likely than not we would be required to sell prior to recovery for debt securities;
•consideration of rating agency actions; and
•changes in estimated cash flows of mortgage and asset backed securities.
We determine whether an allowance for credit loss should be established for debt securities by assessing all facts and circumstances surrounding each security. Where the decline in fair value of debt securities is attributable to changes in market interest rates or to factors such as market volatility, liquidity and spread widening, and we anticipate recovery of all contractual or expected cash flows, we do not consider these investments to have credit loss because we do not intend to sell these investments and it is not more likely than not we will be required to sell these investments before a recovery of amortized cost, which may be maturity.
If we intend to sell a debt security or if it is more likely than not that we will be required to sell a debt security before recovery of its amortized cost basis, credit loss has occurred and the difference between amortized cost and fair value will be recognized as a loss in operations.
If we do not intend to sell and it is not more likely than not we will be required to sell the debt security but also do not expect to recover the entire amortized cost basis of the security, a credit loss would be recognized in operations for the amount of the expected credit loss. We determine the amount of expected credit loss by calculating the present value of the cash flows expected to be collected discounted at each security's acquisition yield based on our consideration of whether the security was of high credit quality at the time of acquisition. The difference between the present value of expected future cash flows and the amortized cost basis of the security is the amount of credit loss recognized in operations. The recognized credit loss is limited to the total unrealized loss on the security (i.e., the fair value floor).
The determination of the credit loss component of a mortgage backed security is based on a number of factors. The primary consideration in this evaluation process is the issuer's ability to meet current and future interest and principal payments as contractually stated at time of purchase. Our review of these securities includes an analysis of the cash flow modeling under various default scenarios considering independent third party benchmarks, the seniority of the specific tranche within the structure of the security, the composition of the collateral and the actual default, loss severity and prepayment experience exhibited. With the input of third party assumptions for default projections, loss severity and prepayment expectations, we evaluate the cash flow projections to determine whether the security is performing in accordance with its contractual obligation.
We utilize models from a leading structured product software specialist serving institutional investors. These models incorporate each security's seniority and cash flow structure. In circumstances where the analysis implies a potential for principal loss at some point in the future, we use the "best estimate" cash flow projection discounted at the security's effective yield at acquisition to determine the amount of our potential credit loss associated with this security. The discounted expected future cash flows equates to our expected recovery value. Any shortfall of the expected recovery when compared to the amortized cost of the security will be recorded as credit loss.
The determination of the credit loss component of a corporate bond is based on the underlying financial performance of the issuer and their ability to meet their contractual obligations. Considerations in our evaluation include, but are not limited to, credit rating changes, financial statement and ratio analysis, changes in management, significant changes in credit spreads, breaches of financial covenants and a review of the economic outlook for the industry and markets in which they trade. In circumstances where an issuer appears unlikely to meet its future obligation, an estimate of credit loss is determined. Credit loss is calculated using default probabilities as derived from the credit default swaps markets in conjunction with recovery rates derived from independent third party analysis or a best estimate of credit loss. This credit loss rate is then incorporated into a present value calculation based on an expected principal loss in the future discounted at the yield at the date of purchase and compared to amortized cost to determine the amount of credit loss associated with the security.
We do not measure a credit loss allowance on accrued interest receivable as we write off any accrued interest receivable balance to net investment income in a timely manner when we have concerns regarding collectability.
Amounts on available for sale fixed maturities that are deemed to be uncollectible are written off and removed from the allowance for credit loss. A write-off may also occur if we intend to sell a security or when it is more likely than not we will be required to sell the security before the recovery of its amortized cost.
18
The following table provides a rollforward of the allowance for credit loss:
| Three Months Ended September 30, 2020 | |||||||||||||||||||||||||||||||||||||||||
| Corporate Securities | Commercial Mortgage Backed Securities | Residential Mortgage Backed Securities | Other Asset Backed Securities | Total | |||||||||||||||||||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||||||||||||||||||||
| Beginning balance | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
| Additions for credit losses not previously recorded | |||||||||||||||||||||||||||||||||||||||||
| Reduction for securities with credit losses due to intent to sell | ( | ( | |||||||||||||||||||||||||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
| Nine Months Ended September 30, 2020 | |||||||||||||||||||||||||||||||||||||||||
| Corporate Securities | Commercial Mortgage Backed Securities | Residential Mortgage Backed Securities | Other Asset Backed Securities | Total | |||||||||||||||||||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||||||||||||||||||||
| Beginning balance (1) | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
| Additions for credit losses not previously recorded | |||||||||||||||||||||||||||||||||||||||||
| Reduction for securities with credit losses due to intent to sell | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
Prior to the implementation of authoritative guidance in 2020, we evaluated our investments for other than temporary impairments using a method consistent with our current credit loss evaluation process discussed above. In addition, we also considered length of time the fair value had been less than amortized cost or cost in our evaluation.
If we did not intend to sell and it was not more likely than not we would be required to sell the debt security but also did not expect to recover the entire amortized cost basis of the security, an impairment loss was recognized in operations in the amount of the expected credit loss. The difference between the present value of expected future cash flows and the amortized cost basis of the security was the amount of credit loss recognized in operations. The remaining amount of the other than temporary impairment was recognized in other comprehensive income.
In addition, for debt securities which we did not intend to sell and it was not more likely than not we would be required to sell, but our intent changed due to changes or events that could not have been reasonably anticipated, an other than temporary impairment charge was recognized. Once an impairment charge had been recorded, we then continued to review the other than temporarily impaired securities for appropriate valuation on an ongoing basis. Unrealized losses may have been recognized in future periods through a charge to earnings should we have later concluded that the decline in fair value below amortized cost was other than temporary pursuant to our accounting policy.
The cumulative portion of other than temporary impairments determined to be credit losses which have been recognized in operations for debt securities are summarized as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2019 | 2019 | ||||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Cumulative credit loss at beginning of period | $ | ( | $ | ( | |||||||||||||||||||
Additions for the amount related to credit losses for which OTTI has not previously been recognized | ( | ||||||||||||||||||||||
Additional credit losses on securities for which OTTI has previously been recognized | ( | ( | |||||||||||||||||||||
| Accumulated losses on securities that were disposed of during the period | |||||||||||||||||||||||
| Cumulative credit loss at end of period | $ | ( | $ | ( | |||||||||||||||||||
19
The following table summarizes the cumulative noncredit portion of OTTI and the change in fair value since recognition of OTTI, both of which were recognized in other comprehensive income, by major type of security, for securities that are part of our investment portfolio at December 31, 2019:
| Amortized Cost | OTTI Recognized in Other Comprehensive Income (Loss) | Change in Fair Value Since OTTI was Recognized | Fair Value | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| December 31, 2019 | |||||||||||||||||||||||
| Fixed maturity securities, available for sale: | |||||||||||||||||||||||
| Corporate securities | $ | $ | ( | $ | $ | ||||||||||||||||||
| Residential mortgage backed securities | ( | ||||||||||||||||||||||
| Commercial mortgage backed securities | ( | ||||||||||||||||||||||
| Other asset backed securities | |||||||||||||||||||||||
| $ | $ | ( | $ | $ | |||||||||||||||||||
4. Mortgage Loans on Real Estate
Our financing receivables consist of the following two portfolio segments: commercial mortgage loans and residential mortgage loans. Our commercial and residential mortgage loan portfolios are summarized in the following table. There were commitments outstanding of $106.1 million at September 30, 2020.
| September 30, 2020 | December 31, 2019 | ||||||||||
| (Dollars in thousands) | |||||||||||
| Commercial mortgage loans: | |||||||||||
| Principal outstanding | $ | $ | |||||||||
| Deferred fees and costs, net | ( | ( | |||||||||
| Amortized cost | |||||||||||
| Valuation allowance | ( | ( | |||||||||
| Commercial mortgage loans, carrying value | |||||||||||
| Residential mortgage loans: | |||||||||||
| Principal outstanding | |||||||||||
| Deferred fees and costs, net | |||||||||||
| Unamortized discounts and premiums, net | ( | ||||||||||
| Amortized cost | |||||||||||
| Valuation allowance | ( | ||||||||||
| Residential mortgage loans, carrying value | |||||||||||
| Mortgage loans, carrying value | $ | $ | |||||||||
20
Our commercial mortgage loan portfolio consists of loans collateralized by the related properties and diversified as to property type, location and loan size. Our lending policies establish limits on the amount that can be loaned to one borrower and other criteria to attempt to reduce the risk of default. The commercial mortgage loan portfolio is summarized by geographic region and property type as follows:
| September 30, 2020 | December 31, 2019 | ||||||||||||||||||||||
| Principal | Percent | Principal | Percent | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Geographic distribution | |||||||||||||||||||||||
| East | $ | % | $ | % | |||||||||||||||||||
| Middle Atlantic | % | % | |||||||||||||||||||||
| Mountain | % | % | |||||||||||||||||||||
| New England | % | % | |||||||||||||||||||||
| Pacific | % | % | |||||||||||||||||||||
| South Atlantic | % | % | |||||||||||||||||||||
| West North Central | % | % | |||||||||||||||||||||
| West South Central | % | % | |||||||||||||||||||||
| $ | % | $ | % | ||||||||||||||||||||
| Property type distribution | |||||||||||||||||||||||
| Office | $ | % | $ | % | |||||||||||||||||||
| Medical Office | % | % | |||||||||||||||||||||
| Retail | % | % | |||||||||||||||||||||
| Industrial/Warehouse | % | % | |||||||||||||||||||||
| Apartment | % | % | |||||||||||||||||||||
| Agricultural | % | % | |||||||||||||||||||||
| Mixed use/Other | % | % | |||||||||||||||||||||
| $ | % | $ | % | ||||||||||||||||||||
Our residential mortgage loan portfolio consists of loans with an outstanding principal balance of $171.9 million that have been purchased throughout 2020. These loans are collateralized by the related properties and diversified as to location within the United States.
Mortgage loans on real estate are generally reported at cost adjusted for amortization of premiums and accrual of discounts, computed using the interest method and net of valuation allowances. Interest income is accrued on the principal amount of the loan based on the loan's contractual interest rate. Interest income is included in Net investment income on our consolidated statements of operations. Accrued interest receivable, which was $14.9 million as of September 30, 2020, is included in Accrued investment income on our consolidated balance sheets.
Loan Valuation Allowance
We establish a valuation allowance to provide for the risk of credit losses inherent in our mortgage loan portfolios. The valuation allowance is maintained at a level believed adequate by management to absorb estimated expected credit losses. The valuation allowance is based on amortized cost, which excludes accrued interest receivable. We do not measure a credit loss allowance on accrued interest receivable as we write off any uncollectible accrued interest receivable balances to net investment income in a timely manner. We did no
The valuation allowance for commercial mortgage loans is calculated by pooling our loans based on risk rating and property collateral type and applying an estimated loss ratio against each risk pool. Risk ratings are based on an analysis of the current state of the borrower's credit quality, which considers factors such as loan-to-value ("LTV") and debt service coverage ("DSC") ratios, loan performance and economic outlook, among others. The loss ratios are generally based upon historical loss experience for each risk pool and are adjusted for current and forecasted economic factors management believes to be relevant and supportable. Economic factors are forecasted for two years with immediate reversion to historical experience.
A commercial loan is individually evaluated for impairment if it does not continue to share similar risk characteristics of a pool. A commercial mortgage loan that is individually evaluated is impaired when it is probable that we will be unable to collect all amounts due according to the contractual terms of the loan agreement. If we determine that the value of any specific mortgage loan is impaired, the carrying amount of the mortgage loan will be reduced to its fair value, based upon the present value of expected future cash flows from the loan discounted at the loan's effective interest rate, or the fair value of the underlying collateral less estimated costs to sell.
The valuation allowance for residential mortgage loans is estimated by deriving probability of default and recovery rate assumptions based on the characteristics of the loans in our portfolio, historical economic data and loss information, and current and forecasted economics conditions. Key loan characteristics impacting the estimate include delinquency status, time to maturity, original credit scores and loan-to-value ratios.
21
The following table represents a rollforward of the valuation allowance on our mortgage loan portfolios:
| Three Months Ended September 30, 2020 | |||||||||||||||||
| Commercial | Residential | Total | |||||||||||||||
| (Dollars in thousands) | |||||||||||||||||
| Beginning allowance balance | $ | ( | $ | ( | $ | ( | |||||||||||
| Charge-offs | |||||||||||||||||
| Recoveries | |||||||||||||||||
| Change in provision for credit losses | ( | ||||||||||||||||
| Ending allowance balance | $ | ( | $ | ( | $ | ( | |||||||||||
| Nine Months Ended September 30, 2020 | |||||||||||||||||
| Commercial | Residential | Total | |||||||||||||||
| (Dollars in thousands) | |||||||||||||||||
| Beginning allowance balance (1) | $ | ( | $ | $ | ( | ||||||||||||
| Charge-offs | |||||||||||||||||
| Recoveries | |||||||||||||||||
| Change in provision for credit losses | ( | ( | ( | ||||||||||||||
| Ending allowance balance | $ | ( | $ | ( | $ | ( | |||||||||||
Credit Quality Indicators
We evaluate the credit quality of our commercial mortgage loans by analyzing LTV and DSC ratios and loan performance. We evaluate the credit quality of our residential mortgage loans by analyzing loan performance.
LTV and DSC ratios for our commercial mortgage loans are originally calculated at the time of loan origination and are updated annually for each loan using information such as rent rolls, assessment of lease maturity dates and property operating statements, which are reviewed in the context of current leasing and in place rents compared to market leasing and market rents. A DSC ratio of less than 1.0 indicates that a property's operations do not generate sufficient income to cover debt payments. An LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the value of the underlying collateral. All of our commercial mortgage loans that have a debt service coverage ratio of less than 1.0 are performing under the original contractual loan terms at September 30, 2020. A summary of our commercial mortgage loan portfolio by LTV and DSC ratios based on the most recent information collected follows (by year of origination):
| 2020 | 2019 | 2018 | 2017 | 2016 | Prior | Total | ||||||||||||||||||||||||||||||||||||||
| As of September 30, 2020: | Amortized Cost | Average LTV | Amortized Cost | Average LTV | Amortized Cost | Average LTV | Amortized Cost | Average LTV | Amortized Cost | Average LTV | Amortized Cost | Average LTV | Amortized Cost | Average LTV | ||||||||||||||||||||||||||||||
| Debt Service Coverage Ratio: | (Dollars in thousands) | |||||||||||||||||||||||||||||||||||||||||||
| Greater than or equal to 1.5 | $ | % | $ | % | $ | % | $ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||||||||
Greater than or equal to 1.2 and less than 1.5 | % | % | % | % | % | % | % | |||||||||||||||||||||||||||||||||||||
Greater than or equal to 1.0 and less than 1.2 | % | % | % | % | % | % | % | |||||||||||||||||||||||||||||||||||||
| Less than 1.0 | % | % | % | % | % | % | % | |||||||||||||||||||||||||||||||||||||
| Total | $ | % | $ | % | $ | % | $ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||||||||
22
We closely monitor loan performance for both our commercial and residential mortgage loan portfolios. Aging of financing receivables is summarized in the following table (by year of origination):
| 2020 | 2019 | 2018 | 2017 | 2016 | Prior | Total | |||||||||||||||||||||||||||||||||||
| As of September 30, 2020: | (Dollars in thousands) | ||||||||||||||||||||||||||||||||||||||||
| Commercial mortgage loans | |||||||||||||||||||||||||||||||||||||||||
| Current | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| 30 - 59 days past due | |||||||||||||||||||||||||||||||||||||||||
| 60 - 89 days past due | |||||||||||||||||||||||||||||||||||||||||
| Over 90 days past due | |||||||||||||||||||||||||||||||||||||||||
| Total commercial mortgage loans | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| Residential mortgage loans | |||||||||||||||||||||||||||||||||||||||||
| Current | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| 30 - 59 days past due | |||||||||||||||||||||||||||||||||||||||||
| 60 - 89 days past due | |||||||||||||||||||||||||||||||||||||||||
| Over 90 days past due | |||||||||||||||||||||||||||||||||||||||||
| Total residential mortgage loans | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
As of December 31, 2019, none of our mortgage loans were 30 days or more past due.
Troubled Debt Restructuring
A Troubled Debt Restructuring ("TDR") is a situation where we have granted a concession to a borrower for economic or legal reasons related to the borrower's financial difficulties that we would not otherwise consider. A mortgage loan that has been granted new terms, including workout terms as described previously, would be considered a TDR if it meets conditions that would indicate a borrower is experiencing financial difficulty and the new terms constitute a concession on our part. We analyze all loans where we have agreed to workout terms and all loans that we have refinanced to determine if they meet the definition of a TDR. We consider the following factors in determining whether or not a borrower is experiencing financial difficulty:
•borrower is in default,
•borrower has declared bankruptcy,
•there is growing concern about the borrower's ability to continue as a going concern,
•borrower has insufficient cash flows to service debt,
•borrower's inability to obtain funds from other sources, and
•there is a breach of financial covenants by the borrower.
If the borrower is determined to be in financial difficulty, we consider the following conditions to determine if the borrower is granted a concession:
•assets used to satisfy debt are less than our recorded investment,
•interest rate is modified,
•maturity date extension at an interest rate less than market rate,
•capitalization of interest,
•delaying principal and/or interest for a period of three months or more, and
•partial forgiveness of the balance or charge-off.
23
5. Derivative Instruments
None of our derivatives qualify for hedge accounting, thus, any change in the fair value of the derivatives is recognized immediately in the consolidated statements of operations. The fair value of our derivative instruments, including derivative instruments embedded in fixed index annuity contracts, presented in the consolidated balance sheets are as follows:
| September 30, 2020 | December 31, 2019 | ||||||||||
| (Dollars in thousands) | |||||||||||
| Assets | |||||||||||
| Derivative instruments | |||||||||||
| Call options | $ | $ | |||||||||
| Other assets | |||||||||||
| Interest rate caps | |||||||||||
| $ | $ | ||||||||||
| Liabilities | |||||||||||
| Policy benefit reserves - annuity products | |||||||||||
| Fixed index annuities - embedded derivatives, net | $ | $ | |||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Change in fair value of derivatives: | |||||||||||||||||||||||
| Call options | $ | $ | ( | $ | ( | $ | |||||||||||||||||
| Interest rate swap | ( | ( | |||||||||||||||||||||
| Interest rate caps | ( | ( | |||||||||||||||||||||
| $ | $ | ( | $ | ( | $ | ||||||||||||||||||
| Change in fair value of embedded derivatives: | |||||||||||||||||||||||
| Fixed index annuities - embedded derivatives | $ | ( | $ | $ | ( | $ | |||||||||||||||||
| Other changes in difference between policy benefit reserves computed using derivative accounting vs. long-duration contracts accounting | |||||||||||||||||||||||
| $ | ( | $ | $ | ( | $ | ||||||||||||||||||
The amounts presented as "Other changes in difference between policy benefit reserves computed using derivative accounting vs. long-duration contracts accounting" represents the total change in the difference between policy benefit reserves for fixed index annuities computed under the derivative accounting standard and the long-duration contracts accounting standard at each balance sheet date, less the change in fair value of our fixed index annuities embedded derivatives that is presented as Level 3 liabilities in Note 2.
We have fixed index annuity products that guarantee the return of principal to the policyholder and credit interest based on a percentage of the gain in a specified market index. When fixed index annuity deposits are received, a portion of the deposit is used to purchase derivatives consisting of call options on the applicable market indices to fund the index credits due to fixed index annuity policyholders. Substantially all such call options are one year options purchased to match the funding requirements of the underlying policies. The call options are marked to fair value with the change in fair value included as a component of revenues. The change in fair value of derivatives includes the gains or losses recognized at the expiration of the option term and the changes in fair value for open positions. On the respective anniversary dates of the index policies, the index used to compute the index credit is reset and we purchase new call options to fund the next index credit. We manage the cost of these purchases through the terms of our fixed index annuities, which permit us to change caps, participation rates, and/or asset fees, subject to guaranteed minimums on each policy's anniversary date. By adjusting caps, participation rates, or asset fees, we can generally manage option costs except in cases where the contractual features would prevent further modifications.
Our strategy attempts to mitigate any potential risk of loss due to the nonperformance of the counterparties to these call options through a regular monitoring process which evaluates the program's effectiveness. We do not purchase call options that would require payment or collateral to another institution and our call options do not contain counterparty credit-risk-related contingent features. We are exposed to risk of loss in the event of nonperformance by the counterparties and, accordingly, we purchase our option contracts from multiple counterparties and evaluate the creditworthiness of all counterparties prior to purchase of the contracts. All non-exchange traded options have been purchased from nationally recognized financial institutions with a Standard and Poor's credit rating of A- or higher at the time of purchase and the maximum credit exposure to any single counterparty is subject to concentration limits. We also have credit support agreements that allow us to request the counterparty to provide collateral to us when the fair value of our exposure to the counterparty exceeds specified amounts.
24
The notional amount and fair value of our call options by counterparty and each counterparty's current credit rating are as follows:
| September 30, 2020 | December 31, 2019 | |||||||||||||||||||||||||||||||||||||
| Counterparty | Credit Rating (S&P) | Credit Rating (Moody's) | Notional Amount | Fair Value | Notional Amount | Fair Value | ||||||||||||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
| Bank of America | A+ | Aa2 | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
| Barclays | A | A1 | ||||||||||||||||||||||||||||||||||||
| Canadian Imperial Bank of Commerce | A+ | Aa2 | ||||||||||||||||||||||||||||||||||||
| Citibank, N.A. | A+ | Aa3 | ||||||||||||||||||||||||||||||||||||
| Credit Suisse | A+ | A1 | ||||||||||||||||||||||||||||||||||||
| J.P. Morgan | A+ | Aa2 | ||||||||||||||||||||||||||||||||||||
| Morgan Stanley | A+ | A1 | ||||||||||||||||||||||||||||||||||||
| Royal Bank of Canada | AA- | A2 | ||||||||||||||||||||||||||||||||||||
| Societe Generale | A | A1 | ||||||||||||||||||||||||||||||||||||
| Truist | A | A2 | ||||||||||||||||||||||||||||||||||||
| Wells Fargo | A+ | Aa2 | ||||||||||||||||||||||||||||||||||||
| Exchange traded | ||||||||||||||||||||||||||||||||||||||
| $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||
As of September 30, 2020 and December 31, 2019, we held $841.6 million and $1.3 billion, respectively, of cash and cash equivalents and other investments from counterparties for derivative collateral, which is included in Other liabilities on our consolidated balance sheets. This derivative collateral limits the maximum amount of economic loss due to credit risk that we would incur if parties to the call options failed completely to perform according to the terms of the contracts to $34.4 million and $25.2 million at September 30, 2020 and December 31, 2019, respectively.
The future index credits on our fixed index annuities are treated as a "series of embedded derivatives" over the expected life of the applicable contract. We do not purchase call options to fund the index liabilities which may arise after the next policy anniversary date. We must value both the call options and the related forward embedded options in the policies at fair value.
6. Notes Payable and Amounts Due Under Repurchase Agreements
Notes payable includes the following:
| September 30, 2020 | December 31, 2019 | ||||||||||
| (Dollars in thousands) | |||||||||||
| Senior notes due 2027 | |||||||||||
| Principal | $ | $ | |||||||||
| Unamortized debt issue costs | ( | ( | |||||||||
| Unamortized discount | ( | ( | |||||||||
| $ | $ | ||||||||||
On June 16, 2017, we issued $500 million aggregate principal amount of senior unsecured notes due 2027 which bear interest at 5.0 % per year and will mature on June 15, 2027 (the "2027 Notes"). The 2027 Notes were issued at a $0.3 million discount, which is being amortized over the term of the 2027 Notes using the effective interest method. Contractual interest is payable semi-annually in arrears each June 15th and December 15th. The initial transaction fees and costs totaling $5.8 million were capitalized as deferred financing costs and are being amortized over the term of the 2027 Notes using the effective interest method.
25
7. Commitments and Contingencies
We are occasionally involved in litigation, both as a defendant and as a plaintiff. In addition, state and federal regulatory bodies, such as state insurance departments, the Securities and Exchange Commission ("SEC") and the Department of Labor, regularly make inquiries and conduct examinations or investigations concerning our compliance with, among other things, insurance laws, securities laws and the Employee Retirement Income Security Act of 1974, as amended.
There can be no assurance that any pending or future litigation will not have a material adverse effect on our business, financial condition, or results of operations.
8. Earnings Per Common Share and Stockholders' Equity
Earnings Per Common Share
The following table sets forth the computation of earnings per common share and earnings per common share - assuming dilution:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands, except per share data) | |||||||||||||||||||||||
| Numerator: | |||||||||||||||||||||||
| Net income available to common stockholders - numerator for earnings per common share | $ | $ | $ | $ | |||||||||||||||||||
| Denominator: | |||||||||||||||||||||||
| Weighted average common shares outstanding | |||||||||||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||||||||
| Stock options and deferred compensation agreements | |||||||||||||||||||||||
| Restricted stock and restricted stock units | |||||||||||||||||||||||
| Denominator for earnings per common share - assuming dilution | |||||||||||||||||||||||
| Earnings per common share | $ | $ | $ | $ | |||||||||||||||||||
| Earnings per common share - assuming dilution | $ | $ | $ | $ | |||||||||||||||||||
During the three months ended September 30, 2020, there were 522,671 options to purchase shares of our common stock outstanding, with an exercise price of $24.71 - $26.70 , excluded from the computation of diluted loss per common share. During the nine months ended September 30, 2020, there were 50,000 options to purchase shares of our common stock outstanding, with an exercise price of $26.70 , excluded from the computation of diluted loss per common share. During the three months ended September 30, 2019, there were 551,585 options to purchase shares of our common stock outstanding, with an exercise price of $24.79 , excluded from the computation of diluted earnings per share. There were no options to purchase shares of our common stock outstanding excluded from the computation of diluted earnings per common share during the nine months ended September 30, 2019, as the exercise price of all options outstanding was less than the average market price of our common shares for those periods.
26
Stockholders' Equity
On June 10, 2020, we issued 12,000 shares of 6.625 % Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B ("Series B") with a $1.00 par value per share and a liquidation preference of $25,000 per share, for aggregate net proceeds of $290.3 million.
On November 21, 2019 we issued 16,000 shares of 5.95 % Fixed-Rate Reset Non-Cumulative Preferred Stock, Series A ("Series A") with a $1.00 par value per share and a liquidation preference of $25,000 per share, for aggregate net proceeds of $388.9 million. We used a portion of the proceeds to redeem all of our floating rate subordinated debentures.
Dividends on the Series A and Series B preferred stock are payable on a non-cumulative basis only when, as and if declared, quarterly in arrears on the first day of March, June, September and December of each year, commencing on March 1, 2020 for Series A and on December 1, 2020 for Series B. On March 1, June 1, and September 1, 2020, we paid dividends totaling $6.6 million, $6.0 million and $5.9 million, respectively, on the Series A preferred stock. The Series A and Series B preferred stock rank senior to our common stock with respect to dividends, to the extent declared, and in liquidation, to the extent of the liquidation preference. The Series A and Series B preferred stock are not subject to any mandatory redemption, sinking fund, retirement fund, purchase fund or similar provisions.
9. Subsequent Events
On October 18, 2020, we announced an agreement with Brookfield Asset Management ("Brookfield") under which Brookfield will acquire up to a 19.9 % ownership interest in the Company. The equity investment by Brookfield will take place in two stages: an initial purchase of a 9.9 % equity interest at $37.00 per share promptly following approval under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, and a second purchase of up to an incremental 10.0 % equity interest, at the greater value of $37.00 per share or adjusted book value per share (excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives). The second equity investment is subject to finalization of a proposed reinsurance transaction that has been agreed to in principle, receipt of applicable regulatory approvals and other closing conditions. In addition, Brookfield has agreed not to transfer any common shares purchased in the equity investment for a period of two years after the applicable closing of the investment, as well as to customary standstill restrictions until the -year anniversary of the initial equity investment, in each case, subject to certain exceptions. Brookfield will also receive one seat on the Company’s Board of Directors following the initial equity investment.
On October 18, 2020, the Company's Board of Directors approved a $500 million share repurchase program. The purpose of the share repurchase program is to both offset dilution from the issuance of shares to Brookfield and to institute a regular cash return program for shareholders. We started the buyback program on October 30, 2020.
27
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's discussion and analysis reviews our unaudited consolidated financial position at September 30, 2020, and the unaudited consolidated results of operations for the three and nine month periods ended September 30, 2020 and 2019, and where appropriate, factors that may affect future financial performance. This analysis should be read in conjunction with our unaudited consolidated financial statements and notes thereto appearing elsewhere in this Form 10-Q, and the audited consolidated financial statements, notes thereto and selected consolidated financial data appearing in our Annual Report on Form 10-K for the year ended December 31, 2019. Interim operating results for the three and nine month periods ended September 30, 2020 are not necessarily indicative of the results expected for the entire year, particularly in light of the material risks and uncertainties surrounding the spread of COVID-19 and the impact it may have on our business, results of operations and financial condition. Preparation of financial statements requires use of management estimates and assumptions. Our estimates and assumptions could change in the future as more information becomes known about the impact of COVID-19.
Cautionary Statement Regarding Forward-Looking Information
All statements, trend analysis and other information contained in this report and elsewhere (such as in filings by us with the SEC, press releases, presentations by us or management or oral statements) may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may relate to markets for our products, trends in our operations or financial results, strategic alternatives, future operations, strategies, plans, partnerships, investments, share buybacks and other financial developments, and are subject to assumptions, risks and uncertainties. Statements such as “guidance”, “expect”, “anticipate”, “strong”, “believe”, “intend”, “goal”, “objective”, “target”, “position”, “potential”, “will”, “may”, “would”, “should”, “can”, “deliver”, “accelerate”, “enable”, “estimate”, “projects”, “outlook”, “opportunity” or similar words, as well as specific projections of future events or results qualify as forward-looking statements. Forward-looking statements, by their nature, are subject to a variety of inherent risks and uncertainties that could cause actual results to differ materially from the results projected. Many of these risks and uncertainties cannot be controlled by the Company. Factors that may cause our actual decisions or results to differ materially from those contemplated by these forward-looking statements include, among other things:
•general economic conditions and other factors, including prevailing interest rate levels and stock and credit market performance which may affect (among other things) our ability to sell our products, our ability to access capital resources and the costs associated therewith, the fair value of our investments, which could result in credit losses, and certain liabilities, and the lapse rate and profitability of policies;
•major public health issues, and specifically the COVID-19 pandemic and the resulting impacts on economic conditions and financial markets;
•customer response to new products and marketing initiatives;
•changes in Federal income tax laws and regulations which may affect the relative income tax advantages of our products;
•increasing competition in the sale of fixed annuities;
•regulatory changes or actions, including those relating to regulation of financial services affecting (among other things) bank sales and underwriting of insurance products and regulation of the sale, underwriting and pricing of products; and
•the risk factors or uncertainties listed from time to time in our filings with the SEC.
A detailed discussion of these and other factors that might affect our performance, can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and in our Quarterly Report on Form 10-Q for the quarterly periods ended March 31, 2020 and June 30, 2020 filed with the SEC. Forward-looking statements speak only as of the date the statement was made and the Company undertakes no obligation to update such forward-looking statements. There can be no assurance that other factors not currently disclosed or anticipated by the Company will not materially adversely affect our results of operations or plans. Investors are cautioned not to place undue reliance on any forward-looking statements made by us or on our behalf.
Our Business and Profitability
We specialize in the sale of individual annuities (primarily fixed and fixed index deferred annuities) through independent marketing organizations ("IMOs"), agents, banks and broker-dealers. Fixed and fixed index annuities are an important product for Americans looking to fund their retirement needs as annuities have the ability to provide retirees a paycheck for life.
The outbreak of the novel coronavirus (COVID-19), recognized as a pandemic by the World Health Organization, has created significant economic and financial turmoil both in the U.S. and around the world which has had a material effect on the global economy and financial markets and raised concerns of a global recession. At this time, it is not possible to predict how COVID-19 will impact the Company, our results of operations or our financial condition and liquidity. See Item 1A. Risk Factors of our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2020 for a discussion of risk factors related to major public health issues, specifically the COVID-19 pandemic.
At the outbreak of COVID-19, we moved decisively to first protect our employees and business partners and then to pivot our operating platform to continue to provide industry leading levels of service to clients and producers, in a prolonged work from home environment. In addition, we increased our liquidity position and held $2.2 billion of unencumbered cash as of September 30, 2020. Currently, most of our employees are working remotely with only operationally critical employees working at our offices in West Des Moines, Iowa.
28
COVID-19 has caused significant economic effects where we operate, including closures of many businesses deemed non-essential due to shelter-in-place, stay-at-home, travel limitations and other governmental regulations or self imposed social distancing practices. These actions have caused disruption to the distribution channels through which we sell our products, including independent agents, and their clients. It is currently unclear how long such COVID-19 related actions will last.
Under U.S. GAAP, premium collections for deferred annuities are reported as deposit liabilities instead of as revenues. Similarly, cash payments to policyholders are reported as decreases in the liabilities for policyholder account balances and not as expenses. Sources of revenues for products accounted for as deposit liabilities are net investment income, surrender charges assessed against policy withdrawals and fees deducted from policyholder account balances for lifetime income benefit riders, net realized gains (losses) on investments and changes in fair value of derivatives. Components of expenses for products accounted for as deposit liabilities are interest sensitive and index product benefits (primarily interest credited to account balances and changes in the liability for lifetime income benefit riders), changes in fair value of embedded derivatives, amortization of deferred sales inducements and deferred policy acquisition costs, other operating costs and expenses and income taxes.
Our profitability depends in large part upon:
•the amount of assets under our management,
•investment spreads we earn on our policyholder account balances,
•our ability to manage our investment portfolio to maximize returns and minimize risks such as interest rate changes and defaults or credit losses,
•our ability to appropriately price for lifetime income benefit riders offered on certain of our fixed rate and fixed index annuity policies,
•our ability to manage interest rates credited to policyholders and costs of the options purchased to fund the annual index credits on our fixed index annuities,
•our ability to manage the costs of acquiring new business (principally commissions paid to agents and distribution partners and bonuses credited to policyholders),
•our ability to manage our operating expenses, and
•income taxes.
We have begun to implement an updated strategy after undertaking a thorough review of our current business, market dynamics and the current interest rate environment. Our updated strategy focuses on four key pillars: Go-to-Market, Investment Management, Capital Structure and Foundational Capabilities.
Go-to-Market focuses on how we generate policyholder funds under management through annuity product sales. We consider our marketing capabilities and franchise to be one of our core competitive strengths. We have become one of the leading insurance companies in the IMO distribution channel over our 25-year history, and can tap into a core set of loyal independent producers to originate new annuity product sales. We are focused on growing our loyal producers with one million dollars or greater of annuity product sales each year. We want to increase our share of annuity product sales generated by IMOs and accelerate our expansion into bank and broker dealer distribution through our subsidiary, Eagle Life Insurance Company ("Eagle Life"). Our strategy is to improve sales execution and enhance producer loyalty with product solutions, focused marketing campaigns, distribution analytics to enhance both sales productivity and producer engagement and new client engagement models that complement traditional physical face-to-face interactions. The financial objectives of our go to market strategy are to accelerate growth of new business and annuity funding origination in normal economic environments and to reduce cost of funds, the total cost of originating an annuity funding.
Investment Management enables the return on assets to generate adequate spread income. In an environment where risk free rates are between zero and one percent, insurers need to invest for better risk-adjusted yields than what are available in traditional fixed income securities. Our investment strategy is to look for opportunities to invest in alpha-producing specialty sub-sectors with contractually strong cash flows like real estate and infrastructure. Our investment management strategy includes forming partnerships with certain asset managers that will provide access to specific asset sectors, resulting in a sustainable supply of quality investment alternatives to traditional fixed income securities. The future partnerships with asset managers may include us taking an equity interest in the asset manager to create greater alignment and allow us to participate in the economics from scaling investment platforms.
Our capital structure plan is to make greater use of reinsurance to enable us to free up capital. We announced on September 28, 2020 an agreement in principle to enter into a strategic partnership with Värde Partners and Agam Capital Management which includes a proposed reinsurance agreement and an asset management joint venture with Värde Partners under which we will cede $5 billion of existing annuity liabilities and free up capital of approximately $350 million. Under the terms of the agreement in principle, Värde Partners will establish a Bermuda reinsurance company that would reinsure $5 billion of our fixed index annuity liabilities. We and Värde Partners will jointly establish an asset management entity to provide insurance asset management services to the reinsurance company. We intend to have a significant minority interest in the new reinsurer and a 35% interest in the newly formed asset management entity. We announced on October 18, 2020 an agreement in principle to enter into a strategic partnership with Brookfield Asset Management ("Brookfield") under which we will cede $5 billion of existing annuity liabilities and up to an incremental $5 billion of new annuity sales; gain access to Brookfield investments in targeted asset classes; and receive a cornerstone investment by Brookfield in which it will acquire up to a 19.9% ownership interest in the Company. The proposed reinsurance agreement with Brookfield will free up approximately $320 to $350 million of capital. We expect to close both transactions in the first half of 2021.
29
The equity investment by Brookfield will take place in two stages: an initial purchase of a 9.9% equity interest at $37.00 per share promptly following approval under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, and a second purchase of up to an incremental 10.0% equity interest, at the greater value of $37.00 per share or adjusted book value per share (excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives). The second equity investment is subject to finalization of certain reinsurance agreement terms, receipt of applicable regulatory approvals and other closing conditions. In addition, Brookfield has agreed not to transfer any common shares purchased in the equity investment for a period of two years after the applicable closing of the investment, as well as to customary standstill restrictions until the five-year anniversary of the initial equity investment, in each case, subject to certain exceptions. Brookfield will also receive one seat on the Company’s Board of Directors following the initial equity investment.
On October 18, 2020, the Company's Board of Directors approved a $500 million share repurchase program. The purpose of the share repurchase program is to both offset dilution from the issuance of shares to Brookfield and to institute a regular cash return program for shareholders. We started the buyback program on October 30, 2020 and expect an accelerated share repurchase program to launch in the fourth quarter.
We plan in the future to establish our own wholly-owned offshore reinsurance company and will seek to raise third-party capital into reinsurance vehicles ("side-cars") to provide risk capital to back a portion of our existing liabilities and future sales of annuity products. This will enable us to convert from an investment spread business with our own capital at risk into a combination spread based and fee based business with externally sourced risk capital. Based on our updated business strategy, we expect to annually return $250 million to $300 million of capital to shareholders starting in 2021.
Foundational Capabilities is focused on upgrading our operating platform to enhance the digital customer experience, create differentiation through data analytics, enhance core technology, and align talent.
Based on our updated strategy, we are targeting operating return on equity in the 11-14% range over the next few years, and above 15%, on average, over the long term.
Life insurance companies are subject to the NAIC risk-based capital ("RBC") requirements and rating agencies utilize a form of RBC to partially determine capital strength of insurance companies. Our RBC ratio at December 31, 2019 was 372%, and our estimated RBC ratio at September 30, 2020 was 382%.
We intend to manage our capitalization in normal economic conditions at a level that is consistent with a 400% RBC ratio; and allow it to drift downwards if necessary to approximately 320% RBC for reasons including, but not limited to, realized credit losses or temporary increases in required risk capital for ratings migrations. This level is intended to reflect a level that is consistent with the rating agencies expectations for capital adequacy ratios at different points in an economic cycle. This implies operating with a peak to trough swing whereby capital is absorbing risk at the low point of the economic cycle. As economic activity recovers, we would expect to grow capital adequacy back to or near the 400% RBC ratio level through a combination of earnings and balance sheet optimization actions while continuing to execute on our core business strategy.
During June of 2020, we strengthened our balance sheet by raising $300 million in preferred equity through the issuance of 12,000 shares of 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock with a liquidation preference of $25,000 per share, for aggregate net proceeds of approximately $290.3 million which is currently held at American Equity Investment Life Holding Company. This provides us a strong capital cushion to weather turbulence from potential ratings migration and credit losses and would provide an additional 27 points of RBC if such proceeds were contributed to American Equity Investment Life Insurance Company.
On August 21, 2020 S&P affirmed its "A-" financial strength rating on American Equity Investment Life Insurance Company and its "BBB-" long-term issuer credit rating on American Equity Investment Life Holding Company, and revised its outlook to "stable" from "negative" primarily due to capital management actions taken throughout the year, including a $200 million contribution from American Equity Investment Life Holding Company to American Equity Investment Life Insurance Company and the issuance of Fixed-Rate Reset Non-Cumulative Stock, Series B for aggregate net proceeds of $290.3 million.
On June 26, 2020, A.M. Best affirmed its "A-" financial strength rating of American Equity Investment Life Insurance Company and its subsidiaries, American Equity Investment Life Insurance Company of New York and Eagle Life Insurance Company, its "bbb-" long-term issuer credit rating of American Equity Investment Life Holding Company, its "bbb-" senior unsecured debt ratings, and its "bb" perpetual, non-cumulative preferred stock ratings. The outlook for these credit ratings of "stable" was also affirmed by A.M. Best on June 26, 2020.
On April 24, 2020, Fitch affirmed its "A-" financial strength rating on American Equity Investment Life Insurance Company and its life insurance subsidiaries, its "BBB" issuer default rating on American Equity Investment Life Holding Company and its "BBB-" senior unsecured debt ratings, but revised its outlook to "negative" from "stable" on its financial strength, issuer default and senior unsecured debt ratings due to disruption to economic activity and the financial markets from the COVID-19 pandemic.
30
Earnings from products accounted for as deposit liabilities are primarily generated from the excess of net investment income earned over the interest credited or the cost of providing index credits to the policyholder, or the "investment spread." Our investment spread is summarized as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| Average yield on invested assets | 4.10% | 4.59% | 4.20% | 4.53% | |||||||||||||||||||
| Aggregate cost of money | 1.66% | 1.84% | 1.71% | 1.87% | |||||||||||||||||||
| Aggregate investment spread | 2.44% | 2.75% | 2.49% | 2.66% | |||||||||||||||||||
| Impact of: | |||||||||||||||||||||||
| Investment yield - additional prepayment income | 0.10% | 0.11% | 0.06% | 0.06% | |||||||||||||||||||
| Cost of money benefit from over (under) hedging | 0.03% | 0.02% | 0.03% | 0.04% | |||||||||||||||||||
The cost of money for fixed index annuities and average crediting rates for fixed rate annuities are computed based upon policyholder account balances and do not include the impact of amortization of deferred sales inducements. See Critical Accounting Policies - Deferred Policy Acquisition Costs and Deferred Sales Inducements included in Management's Discussion and Analysis in our Annual Report on Form 10-K for the year ended December 31, 2019. With respect to our fixed index annuities, the cost of money includes the average crediting rate on amounts allocated to the fixed rate strategy and expenses we incur to fund the annual index credits. Proceeds received upon expiration of call options purchased to fund annual index credits are recorded as part of the change in fair value of derivatives, and are largely offset by an expense for interest credited to annuity policyholder account balances. See Critical Accounting Policies - Policy Liabilities for Fixed Index Annuities and Financial Condition - Derivative Instruments included in Management's Discussion and Analysis in our Annual Report on Form 10-K for the year ended December 31, 2019.
The current environment of low interest rates and low yields for investments with the credit quality we prefer presents a strong headwind to achieving our target rate for investment spread. Active management of policyholder crediting rates has continued to lower the aggregate cost of money. The most recent actions include reductions to caps and crediting rates on $29.7 billion of policyholder funds in January of 2020 and reductions to participation rates on $4.3 billion of policyholder funds in June 2020. We continue to have flexibility to reduce our crediting rates if necessary and could decrease our cost of money by approximately 63 basis points if we reduce current rates to guaranteed minimums. Investment yields on fixed income securities purchased and mortgage loans funded during most of 2020 and 2019 were at average rates below the overall portfolio yield which has resulted in a decrease in the average yield on invested assets. In addition, the decline in yields on our floating rate investment portfolio, mark to market losses on investment partnerships and our decision to hold higher levels of cash and cash equivalents since March of 2020 contributed to the decrease in the average yield on invested assets for the three and nine month periods ended September 30, 2020 compared to the same periods in 2019.
Results of Operations for the Three and Nine Months Ended September 30, 2020 and 2019
Annuity deposits by product type collected during the three and nine months ended September 30, 2020 and 2019, were as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| American Equity Investment Life Insurance Company: | |||||||||||||||||||||||
| Fixed index annuities | $ | 432,602 | $ | 1,054,796 | $ | 1,491,564 | $ | 3,293,458 | |||||||||||||||
| Annual reset fixed rate annuities | 1,817 | 2,340 | 6,464 | 9,402 | |||||||||||||||||||
| Multi-year fixed rate annuities | 531 | 593 | 983 | 1,307 | |||||||||||||||||||
| Single premium immediate annuities | 10,205 | 3,314 | 25,687 | 7,129 | |||||||||||||||||||
| 445,155 | 1,061,043 | 1,524,698 | 3,311,296 | ||||||||||||||||||||
| Eagle Life Insurance Company: | |||||||||||||||||||||||
| Fixed index annuities | 60,476 | 166,081 | 239,349 | 579,119 | |||||||||||||||||||
| Annual reset fixed rate annuities | 39 | — | 97 | 193 | |||||||||||||||||||
| Multi-year fixed rate annuities | 68,206 | 79,000 | 73,386 | 151,572 | |||||||||||||||||||
| 128,721 | 245,081 | 312,832 | 730,884 | ||||||||||||||||||||
| Consolidated: | |||||||||||||||||||||||
| Fixed index annuities | 493,078 | 1,220,877 | 1,730,913 | 3,872,577 | |||||||||||||||||||
| Annual reset fixed rate annuities | 1,856 | 2,340 | 6,561 | 9,595 | |||||||||||||||||||
| Multi-year fixed rate annuities | 68,737 | 79,593 | 74,369 | 152,879 | |||||||||||||||||||
| Single premium immediate annuities | 10,205 | 3,314 | 25,687 | 7,129 | |||||||||||||||||||
| Total before coinsurance ceded | 573,876 | 1,306,124 | 1,837,530 | 4,042,180 | |||||||||||||||||||
| Coinsurance ceded | 5,996 | 86,090 | 29,390 | 212,641 | |||||||||||||||||||
| Net after coinsurance ceded | $ | 567,880 | $ | 1,220,034 | $ | 1,808,140 | $ | 3,829,539 | |||||||||||||||
31
Annuity deposits before and after coinsurance ceded decreased 56% and 53%, respectively, during the third quarter of 2020 compared to the same period in 2019 and decreased 55% and 53%, respectively, during the nine months ended September 30, 2020 compared to the same period in 2019. The decrease in sales for the three and nine months ended September 30, 2020 compared to the same periods in 2019 was primarily due to the impact of the COVID-19 pandemic on limitations of face to face meetings and increased social distancing requirements as well as competitive pressures within each of our distribution channels. We continue to face a challenging environment for sales of fixed index annuities due to a highly competitive market, and until social distancing needs abate or producers find new ways to engage with clients, we would expect sales to remain subdued.
We coinsure 80% of the annuity deposits received from certain multi-year rate guaranteed annuities and 20% of certain fixed index annuities sold by Eagle Life through broker/dealers and banks. The decrease in coinsurance ceded premiums was attributable to a decrease in certain multi-year rate guaranteed annuities and fixed index annuities sold by Eagle Life for the three and nine months ended September 30, 2020 compared to the same periods in 2019.
Net income available to common stockholders increased to $661.3 million in the third quarter of 2020 and to $644.2 million for the nine months ended September 30, 2020 compared to $37.4 million and $25.9 million for the same periods in 2019. The increases in net income available to common stockholders for the three and nine months ended September 30, 2020 were driven primarily by the impact of assumption updates during the third quarter of 2020 compared to the impact of assumption updates during the third quarter of 2019 as further described below.
Net income is impacted by the change in fair value of derivatives and embedded derivatives which fluctuates from period to period based upon changes in fair values of call options purchased to fund the annual index credits for fixed index annuities and changes in interest rates used to discount the embedded derivative liability. Net income for the three and nine months ended September 30, 2020 was negatively impacted by a net decrease in the discount rates used to estimate the fair value of our embedded derivative liabilities, the impact of which was partially offset by decreases in amortization of deferred policy acquisition costs and deferred sales inducements related to the change in fair value of derivatives and embedded derivatives. Net income for the three and nine months ended September 30, 2019 was also negatively impacted by decreases in the discount rates used to estimate the fair value of our embedded derivative liabilities, the impact of which was partially offset by decreases in amortization of deferred policy acquisition costs and deferred sales inducements related to the change in fair value of derivatives and embedded derivatives. See Change in fair value of derivatives, Change in fair value of embedded derivatives, Amortization of deferred sales inducements and Amortization of deferred policy acquisition costs.
Net income, in general, is impacted by the volume of business in force and the investment spread earned on this business. Our investment spread measured in dollars was $318.2 million for the third quarter of 2020 and $966.3 million for the nine months ended September 30, 2020 compared to $344.0 million and $975.3 million for the same periods in 2019. Our investment spread has been negatively impacted by the extended low interest rate environment and by holding higher levels of cash and cash equivalents due to current economic conditions caused by COVID-19 (see Net investment income). The impact of the extended low interest rate environment and higher cash and cash equivalent holdings has been partially offset by a lower aggregate cost of money due to our continued active management of new business and renewal rates.
We periodically update the key assumptions used in the calculation of amortization of deferred policy acquisition costs and deferred sales inducements retrospectively through an unlocking process when estimates of current or future gross profits/margins (including the impact of realized investment gains and losses) to be realized from a group of products are revised. In addition, we periodically update the assumptions used in determining the liability for lifetime income benefit riders and the embedded derivative component of our fixed index annuity policy benefit reserves as experience develops that is different from our assumptions.
Net income available to common stockholders for the 2020 and 2019 periods includes effects from updates to assumptions as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Increase (decrease) in amortization of deferred sales inducements | $ | 391,428 | $ | (104,707) | $ | 428,101 | $ | (104,707) | |||||||||||||||
| Increase (decrease) in amortization of deferred policy acquisition costs | 589,209 | (192,982) | 646,785 | (192,982) | |||||||||||||||||||
| Increase in interest sensitive and index product benefits | 285,825 | 315,383 | 285,825 | 315,383 | |||||||||||||||||||
| Increase (decrease) in change in fair value of embedded derivatives | (2,111,140) | 28,208 | (2,341,279) | 28,208 | |||||||||||||||||||
| Effect on net income available to common stockholders | 663,073 | (35,987) | 769,611 | (35,987) | |||||||||||||||||||
We review these assumptions quarterly and as a result of these reviews, we made updates to assumptions in the second and third quarters of 2020 and the third quarter of 2019. In addition, we implemented an enhanced actuarial valuation system during the third quarter of 2019, and as a result, our third quarter 2019 assumption updates include model refinements resulting from the implementation.
The most significant assumption updates made in the third quarter of 2020 were to investment spread assumptions, including the net investment earned rate and crediting rates on policies, as well as updates to lapse rate and partial withdrawal assumptions.
32
Due to the current economic and low interest rate environments, we updated our assumption for aggregate investment spread to 2.40% in the near-term increasing to 2.60% over an eight-year reversion period and our assumption for crediting/discount rate to 1.60% increasing to 2.10% over an eight-year reversion period. Prior to these assumption updates, our long-term assumption for aggregate investment spread was steady at 2.60%, with a near term crediting/discount rate of 1.90% increasing to 2.90% over a 20-year reversion period. The assumption update to decrease aggregate investment spread resulted in lower expected future gross profits as compared to previous estimates and a decrease in the balances of deferred policy acquisition costs and deferred sales inducements. The decrease in the crediting rate, which is used as the discount rate in the calculation of the liability for lifetime income benefit riders, resulted in an increase in the liability for lifetime income benefit riders.
We updated lapse rate and partial withdrawal assumptions based on actual historical experience. For certain annuity products without a lifetime income benefit rider, lapse rate and partial withdrawal assumptions were increased while for certain annuity products with a lifetime income benefit rider, lapse rate and partial withdrawal assumptions were decreased. The net impact of the updates to lapse rate and partial withdrawal assumptions resulted in lower expected future gross profits as compared to previous estimates and a decrease in the balances of deferred policy acquisition costs and deferred sales inducements. The net impact of the updates to lapse rate and partial withdrawal assumptions resulted in an increase in the liability for lifetime income benefit riders due to a greater amount of expected benefit payments in excess of account values.
The most significant assumption update to the calculation of the fair value of the embedded derivative component of our fixed index annuity policy benefit reserves in the third quarter of 2020 was a decrease in the crediting rate/option budget to 2.10% from 2.90% as a result of a revised estimate of the cost of options. This assumption change resulted in a decrease in the fair value of the embedded derivative component of our fixed index annuity policy benefit reserves due to a reduction in the projected policy contract values over the expected lives of the contracts. The net impact of the the updates to lapse and partial withdrawal assumptions noted above resulted in an increase in the embedded derivative component of our fixed index annuity policy benefit reserves as more funds ultimately qualify for excess benefits.
During the second quarter of 2020, we updated assumptions used in determining the embedded derivative component of our fixed index annuity policy benefit reserves. The revision consisted of a refinement in the derivation of the discount rate used in calculating the fair value of embedded derivatives which increased the discount rate and resulted in a decrease in the change in fair value of embedded derivatives offset by increases in amortization of deferred sales inducements and deferred policy acquisition costs.
The most significant assumption updates made during the third quarter of 2019 were to lapse and utilization assumptions. We had credible lapse and utilization data based upon a comprehensive experience study spanning over 10 years on our products with lifetime income benefit riders and have experienced lapse rates that are lower than previously estimated.
Lower lapse assumptions resulted in an expectation that more policyholders will turn on their lifetime income benefit than previously anticipated which results in a greater amount of benefit payments in excess of account value and the need for a greater liability for lifetime income benefit riders. The decrease in lapse rate assumptions also resulted in policies being in force for a longer period of time and an increase in expected gross profits as compared to previous estimates. The higher level of expected future gross profits resulted in an increase in the balances of deferred policy acquisition costs and deferred sales inducements.
Our historical experience also indicated that the ultimate utilization of certain lifetime income benefit riders was expected to be less than our prior assumptions and the timing of utilization of lifetime income benefit riders is later than in our prior assumptions. We reduced our ultimate utilization assumptions for fee riders from 75% to 60% and for no-fee riders from 37.5% to 30%, for policies issued in 2014 and prior years. The net effect of the utilization assumption revisions resulted in a decrease in the liability for lifetime income benefit riders and partially offset the increase in the reserve for lifetime income benefit riders from the change in lapse assumptions.
In addition, we revised our assumptions regarding future crediting/discount rates. We assumed a 3.80% U.S. Treasury rate with a 20 year mean revision period. Our assumption for aggregate investment spread was 2.60% which translated to an ultimate discount rate of 2.90%. While the aggregate spread of 2.60% did not change from prior estimates, our estimates of the profitability of individual cohorts changed with the use of an aggregate portfolio yield across all cohorts. This assumption revision resulted in a change in the allocation of profitability by cohort, which caused a reduction in the deferred policy acquisition costs and deferred sales inducements assets and partially offset the increase in the deferred policy acquisition costs and deferred sales inducements assets from the change in lapse assumptions.
The most significant updates to the calculation of the fair value of the embedded derivative component of our fixed index annuity policy benefit reserves in the third quarter of 2019 were to decrease lapse rate assumptions as noted above. The impact of the lapse rate assumption changes was partially offset by a decrease in the option budget from 3.10% to 2.90% as a result of a revised estimate of the cost of options over the 20 year mean reversion period.
Net income available to common stockholders for the three and nine months ended September 30, 2020 was negatively impacted by net realized losses on investments primarily as a result of credit losses on available for sale fixed maturity securities (see Net realized gains on investments).
Net income available to common stockholders for the nine months ended September 30, 2020 was impacted by a discrete tax item that provided a tax benefit of $30.1 million related to the provision of the Coronavirus Aid, Relief, and Economic Security Act that allows net operating losses for 2018 through 2020 to be carried back to previous tax years in which a 35% statutory tax rate was in effect.
33
Non-GAAP operating income (loss) available to common stockholders, a non-GAAP financial measure, decreased to $(249.8) million in the third quarter of 2020 and decreased to $(2.6) million for the nine months ended September 30, 2020 compared to $233.4 million and $422.3 million for the same periods in 2019.
In addition to net income available to common stockholders, we have consistently utilized non-GAAP operating income (loss) available to common stockholders, a non-GAAP financial measure commonly used in the life insurance industry, as an economic measure to evaluate our financial performance. Non-GAAP operating income (loss) available to common stockholders equals net income available to common stockholders adjusted to eliminate the impact of items that fluctuate from quarter to quarter in a manner unrelated to core operations, and we believe measures excluding their impact are useful in analyzing operating trends. The most significant adjustments to arrive at non-GAAP operating income (loss) available to common stockholders eliminate the impact of fair value accounting for our fixed index annuity business and are not economic in nature but rather impact the timing of reported results. We believe the combined presentation and evaluation of non-GAAP operating income (loss) available to common stockholders together with net income available to common stockholders provides information that may enhance an investor's understanding of our underlying results and profitability.
Non-GAAP operating income (loss) available to common stockholders is not a substitute for net income available to common stockholders determined in accordance with GAAP. The adjustments made to derive non-GAAP operating income (loss) available to common stockholders are important to understand our overall results from operations and, if evaluated without proper context, non-GAAP operating income (loss) available to common stockholders possesses material limitations. As an example, we could produce a low level of net income available to common stockholders or a net loss available to common stockholders in a given period, despite strong operating performance, if in that period we experience significant net realized losses from our investment portfolio. We could also produce a high level of net income available to common stockholders in a given period, despite poor operating performance, if in that period we generate significant net realized gains from our investment portfolio. As an example of another limitation of non-GAAP operating income (loss) available to common stockholders, it does not include the decrease in cash flows expected to be collected as a result of credit losses on financial assets. Therefore, our management reviews net realized investment gains (losses) and analyses of our net investment income, including impacts related to credit losses, in connection with their review of our investment portfolio. In addition, our management examines net income available to common stockholders as part of their review of our overall financial results.
The adjustments made to net income available to common stockholders to arrive at non-GAAP operating income (loss) available to common stockholders for the three and nine months ended September 30, 2020 and 2019 are set forth in the table that follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Reconciliation from net income available to common stockholders to non-GAAP operating income (loss) available to common stockholders: | |||||||||||||||||||||||
| Net income available to common stockholders | $ | 661,250 | $ | 37,360 | $ | 644,207 | $ | 25,940 | |||||||||||||||
| Adjustments to arrive at non-GAAP operating income (loss) available to common stockholders: | |||||||||||||||||||||||
| Net realized gains/losses on financial assets, including credit losses | 15,145 | (3,175) | 49,986 | (245) | |||||||||||||||||||
| Change in fair value of derivatives and embedded derivatives - fixed index annuities | (1,176,909) | 250,186 | (873,773) | 500,998 | |||||||||||||||||||
| Change in fair value of derivatives - interest rate caps and swap | — | (76) | (848) | 1,414 | |||||||||||||||||||
| Income taxes | 250,701 | (50,940) | 177,804 | (105,759) | |||||||||||||||||||
| Non-GAAP operating income (loss) available to common stockholders | $ | (249,813) | $ | 233,355 | $ | (2,624) | $ | 422,348 | |||||||||||||||
The amounts disclosed in the reconciliation above are presented net of related adjustments to amortization of deferred sales inducements and deferred policy acquisition costs where applicable.
Non-GAAP operating income (loss) available to common stockholders for the 2020 and 2019 periods includes effects from updates to assumptions as follows:
| Three and Nine Months Ended September 30, | |||||||||||||||||||||||
| 2020 | 2019 | ||||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Increase (decrease) in amortization of deferred sales inducements | $ | 57,467 | $ | (184,882) | |||||||||||||||||||
| Increase (decrease) in amortization of deferred policy acquisition costs | 90,970 | (288,332) | |||||||||||||||||||||
| Increase in interest sensitive and index product benefits | 285,825 | 315,383 | |||||||||||||||||||||
| Effect on non-GAAP operating income (loss) available to common stockholders | (340,895) | 123,739 | |||||||||||||||||||||
34
The impact to net income available to common stockholders and non-GAAP operating income (loss) available to common stockholders from assumption updates varies due to the impact of fair value accounting for our fixed index annuity business as non-GAAP operating income (loss) available to common stockholders eliminates the impact of fair value accounting for our fixed index annuity business. While the assumption updates made during 2020 and 2019 were consistently applied, the impact to net income available to common stockholders and non-GAAP operating income (loss) available to common stockholders varies due to different amortization rates being applied to gross profit adjustments included in the valuation.
The changes in non-GAAP operating income (loss) available to common stockholders for the three and nine months ended September 30, 2020 compared to the same periods in 2019 were primarily a result of the impact of assumption updates as previously noted. Non-GAAP operating income available to common stockholders adjusted for the impact of updates to assumptions for the three and nine months ended September 30, 2020 decreased compared to the same periods in 2019 due to lower investment income and a greater increase in the liability for lifetime income benefit riders partially offset by a decline in deferred policy acquisition cost and deferred sales inducement amortization. The increase in the liability for lifetime income benefit riders and the decline in deferred policy acquisition cost and deferred sales inducement amortization were primarily a result of actuarial updates made in the third quarters of 2020 and 2019 and the impact such updates had on the pattern of the increase in the liability for lifetime income benefit riders and the pattern of deferred policy acquisition cost and deferred sales inducement amortization. In addition, non-GAAP operating income (loss) available to common stockholders for the nine months ended September 30, 2020 was impacted by a $30.1 million tax benefit from a discrete tax item related to the Coronavirus Aid, Relief, and Economic Security Act. See Net income available to common stockholders.
Annuity product charges (surrender charges assessed against policy withdrawals and fees deducted from policyholder account balances for lifetime income benefit riders) decreased 2% to $62.3 million in the third quarter of 2020 and increased 4% to $185.3 million for the nine months ended September 30, 2020 compared to $63.6 million and $177.3 million for the same periods in 2019. The components of annuity product charges are set forth in the table that follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Surrender charges | $ | 16,447 | $ | 20,537 | $ | 55,542 | $ | 56,473 | |||||||||||||||
| Lifetime income benefit riders (LIBR) fees | 45,830 | 43,110 | 129,722 | 120,840 | |||||||||||||||||||
| $ | 62,277 | $ | 63,647 | $ | 185,264 | $ | 177,313 | ||||||||||||||||
| Withdrawals from annuity policies subject to surrender charges | $ | 176,442 | $ | 201,392 | $ | 573,419 | $ | 511,236 | |||||||||||||||
| Average surrender charge collected on withdrawals subject to surrender charges | 9.3 | % | 10.2 | % | 9.7 | % | 11.0 | % | |||||||||||||||
| Fund values on policies subject to LIBR fees | $ | 5,789,502 | $ | 5,674,545 | $ | 16,821,767 | $ | 16,365,077 | |||||||||||||||
| Weighted average per policy LIBR fee | 0.79 | % | 0.76 | % | 0.77 | % | 0.74 | % | |||||||||||||||
The decrease in annuity product charges for the three months ended September 30, 2020 compared to the same period in 2019 was attributable to a decrease in withdrawals from annuity policies subject to surrender charges and lower average surrender charges collected on those withdrawals partially offset by an increase in fees assessed for lifetime income benefit riders due to a larger volume of business subject to the fee and an increase in the average fees being charged. The increase in annuity product charges for the nine months ended September 30, 2020 compared to the same period in 2019 was attributable to an increase in fees assessed for lifetime income benefit riders due to a larger volume of business in force subject to the fee and increases in the average fees being charged partially offset by lower average surrender charges collected on withdrawals from annuity policies subject to surrender charges. See Interest sensitive and index product benefits below for corresponding expense recognized on lifetime income benefit riders.
Net investment income decreased 8% to $543.3 million in the third quarter of 2020 and 3% to $1,660.4 million for the nine months ended September 30, 2020 compared to $590.4 million and $1,719.4 million for the same periods in 2019. The decreases were attributable to a decrease in average yield earned on average invested assets during the three and nine months ended September 30, 2020 compared to the same periods in 2019, partially offset by increases in our average invested assets during the three and nine months ended September 30, 2020 compared to the same periods in 2019. Average invested assets excluding derivative instruments (on an amortized cost basis) increased 3% to $53.0 billion for the third quarter of 2020 and 4% to $52.8 billion for the nine months ended September 30, 2020 compared to $51.5 billion and $50.7 billion for the same periods in 2019.
35
The average yield earned on average invested assets was 4.10% for the third quarter of 2020 and 4.20% for the nine months ended September 30, 2020 compared to 4.59% and 4.53% for the same periods in 2019. The decrease in average yield earned for the three and nine months ended September 30, 2020 compared to the same periods in 2019 was primarily attributable to investment of new premiums and portfolio cash flows during most of 2020 and 2019 at average rates below the overall portfolio yield, a decline in yields on our floating rate investment portfolio due to decreases in the average benchmark rates associated with these investments, an increase in the level of cash and cash equivalent holdings due to our decision to hold higher levels of cash and cash equivalents since March 2020 and mark to market losses on investment partnerships during the nine months ended September 30, 2020 due to changes in fair market valuations. The average yield on fixed income securities purchased and mortgage loans funded during the three and nine months ended September 30, 2020 was 3.59% and 3.75%, compared to 3.30% and 3.95% for the same periods in 2019. During the second and third quarter of 2020 we began to purchase residential mortgage loans which provided a meaningful increase in purchase yields for the three and nine months ended September 30, 2020.
Change in fair value of derivatives consists of call options purchased to fund annual index credits on fixed index annuities, and an interest rate swap and interest rate caps that hedge our floating rate subordinated debentures. The components of change in fair value of derivatives are as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Call options: | |||||||||||||||||||||||
| Loss on option expiration | $ | (3,228) | $ | (106,440) | $ | (2,492) | $ | (272,603) | |||||||||||||||
| Change in unrealized gains/losses | 208,239 | 86,443 | (406,771) | 714,714 | |||||||||||||||||||
| Interest rate swap | — | (3) | — | (1,059) | |||||||||||||||||||
| Interest rate caps | — | (42) | 62 | (580) | |||||||||||||||||||
| $ | 205,011 | $ | (20,042) | $ | (409,201) | $ | 440,472 | ||||||||||||||||
The differences between the change in fair value of derivatives between periods for call options are primarily due to the performance of the indices upon which our call options are based which impacts the fair values and changes in the fair values of those call options between periods. The change in unrealized gains/losses on call options for the three and nine months ended September 30, 2020 as compared to the same periods in 2019 reflect the impact from equity market volatility throughout 2020 related to the economic uncertainty caused by the COVID-19 pandemic. A substantial portion of our call options are based upon the S&P 500 Index with the remainder based upon other equity and bond market indices. The range of index appreciation (after applicable caps, participation rates and asset fees) for options expiring during the three and nine months ended September 30, 2020 and 2019 is as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| S&P 500 Index | |||||||||||||||||||||||
| Point-to-point strategy | 0.6% - 11.6% | 0.0% - 7.0% | 0.0% - 17.4% | 0.0% - 7.0% | |||||||||||||||||||
| Monthly average strategy | 0.0% - 8.0% | 0.0% - 3.5% | 0.0% - 11.9% | 0.0% - 6.9% | |||||||||||||||||||
| Monthly point-to-point strategy | 0.0% - 0.2% | 0.0% - 2.1% | 0.0% - 14.0% | 0.0% - 4.3% | |||||||||||||||||||
| Fixed income (bond index) strategies | 0.0% - 11.1% | 0.0% - 10.0% | 0.0% - 13.6% | 0.0% - 10.0% | |||||||||||||||||||
The change in fair value of derivatives is also influenced by the aggregate cost of options purchased. The aggregate cost of options for the three and nine months ended September 30, 2020 were lower than for the same periods in 2019 as option costs generally decreased during 2019 and into 2020. The decrease in aggregate option costs was partially offset by an increase in the amount of fixed index annuities in force during the three and nine months ended September 30, 2020 compared to the same periods in 2019. The aggregate cost of options is also influenced by the amount of policyholder funds allocated to the various indices and market volatility which affects option pricing. See Critical Accounting Policies - Policy Liabilities for Fixed Index Annuities included in Management's Discussion and Analysis in our Annual Report on Form 10-K for the year ended December 31, 2019.
Net realized gains (losses) on investments includes gains and losses on the sale of securities and other investments and credit losses on our securities and mortgage loans on real estate. Net realized gains (losses) on investments fluctuate from year to year primarily due to changes in the interest rate and economic environment and the timing of the sale of investments. See Note 3 to our unaudited consolidated financial statements and Financial Condition - Credit Losses for a detailed presentation of the types of investments that generated the gains (losses) as well as discussion of credit losses on our securities recognized during the periods presented and Financial Condition - Investments and Note 4 to our unaudited consolidated financial statements for discussion of credit losses recognized on mortgage loans on real estate.
During the nine months ended September 30, 2020, securities were sold at gains as we looked to increase our cash and cash equivalent holdings in response to the COVID-19 pandemic. Securities sold at losses are generally due to our long-term fundamental concern with the issuers' ability to meet their future financial obligations or to improve our risk or duration profiles as they pertain to our asset liability management.
36
Interest sensitive and index product benefits increased 15% to $576.1 million in the third quarter of 2020 and 37% to $1.2 billion for the nine months ended September 30, 2020 compared to $500.3 million and $888.1 million for the same periods in 2019. The components of interest sensitive and index product benefits are summarized as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Index credits on index policies | $ | 174,747 | $ | 92,343 | $ | 551,562 | $ | 310,020 | |||||||||||||||
| Interest credited (including changes in minimum guaranteed interest for fixed index annuities) | 48,042 | 51,706 | 148,078 | 153,110 | |||||||||||||||||||
| Lifetime income benefit riders | 353,358 | 356,236 | 517,718 | 424,932 | |||||||||||||||||||
| $ | 576,147 | $ | 500,285 | $ | 1,217,358 | $ | 888,062 | ||||||||||||||||
The increase in index credits for the three and nine months ended September 30, 2020 compared to the same periods in 2019 were due to changes in the level of appreciation of the underlying indices (see discussion above under Change in fair value of derivatives) and the amount of funds allocated by policyholders to the respective index options. Total proceeds received upon expiration of the call options purchased to fund the annual index credits were $178.4 million and $560.7 million for the three and nine months ended September 30, 2020, compared to $95.5 million and $320.4 million for the same periods in 2019. The changes in benefits recognized for lifetime income benefit riders for the three and nine months ended September 30, 2020 compared to the same periods in 2019 were primarily due to the impact that assumption updates made during the third quarter of 2020 and 2019 had on the lifetime income benefit riders liability and the pattern of growth of the liability due to those assumption updates. The assumption updates used in determining the liability for lifetime income benefit riders resulted in an increase in the liability for lifetime income benefit riders in both 2020 and 2019. (See Net income above for a discussion of the impact of assumption updates). Benefits recognized for lifetime income benefit riders increased for the three and nine months ended September 30, 2020 as compared to the same periods in 2019 due to an increase in fund value of policies with lifetime income benefit riders, which correlates to the increase in fees discussed in Annuity product charges.
The liability (net of coinsurance ceded) for lifetime income benefit riders was $1.8 billion and $1.3 billion at September 30, 2020 and December 31, 2019, respectively.
Amortization of deferred sales inducements before gross profit adjustments increased for the three and nine months ended September 30, 2020 compared to the same periods in 2019 primarily due to the impact of assumption updates made during the third quarter of 2020 as compared to the impact of assumption updates made during the third quarter of 2019. Bonus products represented 76% and 78% of our net annuity account values at September 30, 2020 and September 30, 2019, respectively. The amount of amortization is affected by amortization associated with fair value accounting for derivatives and embedded derivatives utilized in our fixed index annuity business and amortization associated with net realized gains (losses) on investments including credit losses on fixed maturity securities. Fair value accounting for derivatives and embedded derivatives utilized in our fixed index annuity business creates differences in the recognition of revenues and expenses from derivative instruments including the embedded derivative liabilities in our fixed index annuity contracts. The change in fair value of the embedded derivatives will not correspond to the change in fair value of the derivatives (purchased call options), because the purchased call options are one-year options while the options valued in the fair value of embedded derivatives cover the expected lives of the contracts which typically exceed ten years.
Amortization of deferred sales inducements is summarized as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Amortization of deferred sales inducements before gross profit adjustments | $ | 113,273 | $ | (113,177) | $ | 197,514 | $ | 24,512 | |||||||||||||||
| Gross profit adjustments: | |||||||||||||||||||||||
| Fair value accounting for derivatives and embedded derivatives | 305,981 | 57,102 | 224,938 | (26,319) | |||||||||||||||||||
| Net realized gains (losses) on investments | (2,271) | 306 | (7,056) | (868) | |||||||||||||||||||
| Amortization of deferred sales inducements after gross profit adjustments | $ | 416,983 | $ | (55,769) | $ | 415,396 | $ | (2,675) | |||||||||||||||
See Net income and Non-GAAP operating income (loss) above for discussion of the impact of assumption updates on amortization of deferred sales inducements for the three and nine months ended September 30, 2020 and 2019. See Critical Accounting Policies - Deferred Policy Acquisition Costs and Deferred Sales Inducements included in Management's Discussion and Analysis in our Annual Report on Form 10-K for the year ended December 31, 2019.
37
Change in fair value of embedded derivatives includes changes in the fair value of our fixed index annuity embedded derivatives (see Note 5 to our unaudited consolidated financial statements). The components of change in fair value of embedded derivatives are as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Fixed index annuities - embedded derivatives | $ | (2,021,513) | $ | 24,998 | $ | (2,392,600) | $ | 882,230 | |||||||||||||||
| Other changes in difference between policy benefit reserves computed using derivative accounting vs. long-duration contracts accounting | 289,016 | 187,280 | 536,977 | 423,933 | |||||||||||||||||||
| $ | (1,732,497) | $ | 212,278 | $ | (1,855,623) | $ | 1,306,163 | ||||||||||||||||
The change in fair value of the fixed index annuity embedded derivatives resulted from (i) changes in the expected index credits on the next policy anniversary dates, which are related to the change in fair value of the call options acquired to fund those index credits discussed above in Change in fair value of derivatives; (ii) changes in the expected annual cost of options we will purchase in the future to fund index credits beyond the next policy anniversary: (iii) changes in the discount rates used in estimating our embedded derivative liabilities; and (iv) the growth in the host component of the policy liability. The amounts presented as "Other changes in difference between policy benefit reserves computed using derivative accounting vs. long-duration contracts accounting" represent the total change in the difference between policy benefit reserves for fixed index annuities computed under the derivative accounting standard and the long-duration contracts accounting standard at each balance sheet date, less the change in fair value of our fixed index annuities embedded derivative. See Critical Accounting Policies - Policy Liabilities for Fixed Index Annuities included in Management's Discussion and Analysis in our Annual Report on Form 10-K for the year ended December 31, 2019.
The primary reason for the decreases in the change in fair value of the fixed index annuity embedded derivatives during the three and nine months ended September 30, 2020 compared to the same periods of 2019 was a decrease in the expected cost of annual call options we will purchase in the future to fund index credits beyond the next policy anniversary date as a result of updates to assumptions made during the three months ended September 30, 2020. See Net Income above for discussion of the impact of assumption updates on the fair value of the fixed index annuity embedded derivative for the three and nine months ended September 30, 2020 and 2019. In addition, a decrease in the expected index credits on the next policy anniversary dates resulting from decreases in the fair value of the call options acquired to fund these index credits during the nine months ended September 30, 2020 compared to increases in the expected index credits resulting from increases in the fair value of the call options acquired to fund these index credits during the nine months ended September 30, 2019 resulted in a decrease in the change in fair value of the fixed annuity embedded derivatives for the nine-months ended September 30, 2020 compared to the same period of 2019 while an increase in such expected index credits due to a larger increase in the fair value of the call options acquired to fund such index credits for the three months ended September 30, 2020 compared to the same period of 2019 resulted in an increase in the fair value of the fixed index annuity embedded derivatives for the three months ended September 30, 2020 compared to the same period of 2019. These decreases in the fair value of the fixed index annuity embedded derivatives for the nine months ended September 30, 2020 were partially offset by a larger decrease in the net discount rate during the nine months ended September 30, 2020 compared to the same period of 2019. The decrease in the net discount rate for the nine months ended September 30, 2020 consists of a decrease in treasury rates partially offset by a widening of credit spreads. The discount rates used in estimating our embedded derivative liabilities fluctuate based on the changes in the general level of risk free interest rates and our own credit spread.
Amortization of deferred policy acquisition costs before gross profit adjustments increased for the three and nine months ended September 30, 2020 compared to the same periods in 2019 primarily due to the impact of assumption updates made during the third quarter of 2020 as compared to the impact of assumption updates made during the third quarter of 2019. The amount of amortization is affected by amortization associated with fair value accounting for derivatives and embedded derivatives utilized in our fixed index annuity business and amortization associated with net realized gains (losses) on investments including credit losses on fixed maturity securities. As discussed above, fair value accounting for derivatives and embedded derivatives utilized in our fixed index annuity business creates differences in the recognition of revenues and expenses from derivative instruments including the embedded derivative liabilities in our fixed index annuity contracts.
Amortization of deferred policy acquisition costs is summarized as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Amortization of deferred policy acquisition costs before gross profit adjustments | $ | 173,508 | $ | (182,353) | $ | 301,004 | $ | 19,162 | |||||||||||||||
| Gross profit adjustments: | |||||||||||||||||||||||
| Fair value accounting for derivatives and embedded derivatives | 452,694 | 60,674 | 333,319 | (64,259) | |||||||||||||||||||
| Net realized gains (losses) on investments | (3,606) | 745 | (10,914) | (759) | |||||||||||||||||||
| Amortization of deferred policy acquisition costs after gross profit adjustments | $ | 622,596 | $ | (120,934) | $ | 623,409 | $ | (45,856) | |||||||||||||||
38
See Net income and Non-GAAP operating income (loss) above for discussion of the impact of assumption updates on amortization of deferred policy acquisition costs for the three and nine months ended September 30, 2020 and 2019. See Critical Accounting Policies - Deferred Policy Acquisition Costs and Deferred Sales Inducements included in Management's Discussion and Analysis in our Annual Report on Form 10-K for the year ended December 31, 2019.
Other operating costs and expenses increased 11% to $42.7 million in the third quarter of 2020 and 12% to $128.3 million for the nine months ended September 30, 2020 compared to $38.6 million and $115.0 million for the same periods in 2019 and are summarized as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Salary and benefits | $ | 24,966 | $ | 20,170 | $ | 68,953 | $ | 61,263 | |||||||||||||||
| Risk charges | 11,387 | 10,031 | 33,334 | 28,062 | |||||||||||||||||||
| Other | 6,385 | 8,353 | 26,028 | 25,634 | |||||||||||||||||||
| Total other operating costs and expenses | $ | 42,738 | $ | 38,554 | $ | 128,315 | $ | 114,959 | |||||||||||||||
Salary and benefits for the three and nine months ended September 30, 2020 reflect increases of $6.0 million and $2.6 million, respectively, due to an increased number of employees related to our growth and increases of $2.2 million and $2.4 million, respectively, for expense recognized under our equity and cash incentive compensation programs ("incentive compensation programs") compared to the same periods in the prior year. The increases in expenses related to our incentive compensation programs for the three and nine months ended September 30, 2020 were primarily due to an increase in the percentage of performance-based restricted stock units expected to be earned and an increase in expected payouts due to a larger number of employees participating in incentive compensation programs in 2020 as compared to 2019.
The increase in risk charges expense for the three and nine months ended September 30, 2020 compared to the same periods in 2019 was due to an increase in the amount of excess regulatory reserves ceded to an unaffiliated reinsurer. The excess regulatory reserves ceded at September 30, 2020 and 2019 were $1,332.2 million and $1,132.2 million, respectively.
Other expenses decreased for the three months ended September 30, 2020 compared to the same period in 2019 primarily as a result of decreases in expenses related to lower sales production activity due to the COVID-19 pandemic offset by increases in consulting fees. Other expenses increased for the nine months ended September 30, 2020 compared to the same period in 2019 primarily as a result of increases in consulting fees, depreciation and maintenance expense related to software and hardware assets, licensing fees which are based on the level of policyholder funds under management allocated to index strategies and non-deferrable commission expenses. These increases were offset by decreases in expenses related to lower sales promotion activity due to the COVID-19 pandemic.
Income tax expense was $184.6 million in the third quarter of 2020 and $143.3 million for the nine months ended September 30, 2020 compared to $13.6 million and $8.8 million for the same periods in 2019. The change in income tax expense was primarily due to changes in income before income taxes. The effective income tax rates for the three and nine months ended September 30, 2020 were 21.7% and 17.8%, respectively, and 26.8% and 25.3% for the same periods in 2019, respectively.
Income tax expense and the resulting effective tax rate are based upon two components of income before income taxes ("pretax income") that are taxed at different tax rates. Life insurance income is generally taxed at an effective rate of approximately 21.5% reflecting the absence of state income taxes for substantially all of the states that the life insurance subsidiaries do business in. The income for the parent company and other non-life insurance subsidiaries (the "non-life insurance group") is generally taxed at an effective tax rate of 29.5% reflecting the combined federal / state income tax rates. The effective income tax rates resulting from the combination of the income tax provisions for the life / non-life sources of income vary from period to period based primarily on the relative size of pretax income from the two sources.
The effective tax rate for the nine months ended September 30, 2020 was impacted by a discrete tax item that provided a tax benefit of $30.1 million related to the provision of the Coronavirus Aid, Relief, and Economic Security Act that allows net operating losses for 2018 through 2020 to be carried back to previous tax years in which a 35% statutory tax rate was in effect. In addition, the effective income tax rate was impacted by a discrete tax item related to share-based compensation that provided a tax benefit (expense) of approximately $0.4 million for the nine months ended September 30, 2020 compared to $1.3 million for the nine months ended September 30, 2019. Income tax expense for the three and nine months ended September 30, 2019 reflects an increase in income tax expense of approximately $2.5 million related to the reversal of the impact of capital losses expected to be carried back to periods in which a 35% statutory rate was in effect. The effective income tax rates excluding the impact of discrete items were 21.57% and 21.55%, respectively, for the three and nine months ended September 30, 2020 and 21.50% and 21.53% for the same periods in 2019, respectively.
39
Financial Condition
Investments
Our investment strategy is to maintain a predominantly investment grade fixed income portfolio, provide adequate liquidity to meet our cash obligations to policyholders and others and maximize current income and total investment return through active investment management. Consistent with this strategy, our investments principally consist of fixed maturity securities and mortgage loans on real estate.
Insurance statutes regulate the type of investments that our life subsidiaries are permitted to make and limit the amount of funds that may be used for any one type of investment. In light of these statutes and regulations and our business and investment strategy, we generally seek to invest in United States government and government-sponsored agency securities, corporate securities, residential and commercial mortgage backed securities, other asset backed securities and United States municipalities, states and territories securities rated investment grade by established NRSRO's or in securities of comparable investment quality, if not rated and mortgage loans on real estate.
The composition of our investment portfolio is summarized as follows:
| September 30, 2020 | December 31, 2019 | ||||||||||||||||||||||
| Carrying Amount | Percent | Carrying Amount | Percent | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||
| United States Government full faith and credit | $ | 38,739 | 0.1 | % | $ | 161,765 | 0.3 | % | |||||||||||||||
| United States Government sponsored agencies | 1,074,978 | 1.9 | % | 625,020 | 1.1 | % | |||||||||||||||||
| United States municipalities, states and territories | 3,805,086 | 6.7 | % | 4,527,671 | 7.9 | % | |||||||||||||||||
| Foreign government obligations | 209,233 | 0.4 | % | 205,096 | 0.3 | % | |||||||||||||||||
| Corporate securities | 33,457,290 | 58.7 | % | 32,536,839 | 57.2 | % | |||||||||||||||||
| Residential mortgage backed securities | 1,623,073 | 2.8 | % | 1,575,664 | 2.8 | % | |||||||||||||||||
| Commercial mortgage backed securities | 5,478,783 | 9.6 | % | 5,786,279 | 10.2 | % | |||||||||||||||||
| Other asset backed securities | 6,013,561 | 10.5 | % | 6,162,156 | 10.8 | % | |||||||||||||||||
| Total fixed maturity securities | 51,700,743 | 90.7 | % | 51,580,490 | 90.6 | % | |||||||||||||||||
| Mortgage loans on real estate | 3,926,699 | 6.9 | % | 3,448,793 | 6.1 | % | |||||||||||||||||
| Derivative instruments | 874,741 | 1.5 | % | 1,355,989 | 2.4 | % | |||||||||||||||||
| Other investments | 495,740 | 0.9 | % | 492,301 | 0.9 | % | |||||||||||||||||
| $ | 56,997,923 | 100.0 | % | $ | 56,877,573 | 100.0 | % | ||||||||||||||||
Fixed Maturity Securities
Our fixed maturity security portfolio is managed to minimize risks such as interest rate changes and defaults or impairments while earning a sufficient and stable return on our investments. The largest portion of our fixed maturity securities are in investment grade (NAIC designation 1 or 2) publicly traded or privately placed corporate securities.
A summary of our fixed maturity securities by NRSRO ratings is as follows:
| September 30, 2020 | December 31, 2019 | |||||||||||||||||||||||||
| Rating Agency Rating | Carrying Amount | Percent of Fixed Maturity Securities | Carrying Amount | Percent of Fixed Maturity Securities | ||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||
| Aaa/Aa/A | $ | 29,855,053 | 57.8 | % | $ | 30,662,644 | 59.4 | % | ||||||||||||||||||
| Baa | 19,893,094 | 38.5 | % | 19,833,309 | 38.4 | % | ||||||||||||||||||||
| Total investment grade | 49,748,147 | 96.3 | % | 50,495,953 | 97.8 | % | ||||||||||||||||||||
| Ba | 1,573,650 | 3.0 | % | 821,902 | 1.6 | % | ||||||||||||||||||||
| B | 224,170 | 0.4 | % | 81,407 | 0.2 | % | ||||||||||||||||||||
| Caa | 65,386 | 0.1 | % | 95,676 | 0.2 | % | ||||||||||||||||||||
| Ca and lower | 89,390 | 0.2 | % | 85,552 | 0.2 | % | ||||||||||||||||||||
| Total below investment grade | 1,952,596 | 3.7 | % | 1,084,537 | 2.2 | % | ||||||||||||||||||||
| $ | 51,700,743 | 100.0 | % | $ | 51,580,490 | 100.0 | % | |||||||||||||||||||
40
The NAIC's Securities Valuation Office ("SVO") is responsible for the day-to-day credit quality assessment and the valuation of fixed maturity securities owned by state regulated insurance companies. The purpose of such assessment and valuation is for determining regulatory capital requirements and regulatory reporting. Insurance companies report ownership to the SVO when such securities are eligible for regulatory filings. The SVO conducts credit analysis on these securities for the purpose of assigning a NAIC designation and/or unit price. Typically, if a security has been rated by an NRSRO, the SVO utilizes that rating and assigns an NAIC designation based upon the following system:
| NAIC Designation | NRSRO Equivalent Rating | |||||||
| 1 | Aaa/Aa/A | |||||||
| 2 | Baa | |||||||
| 3 | Ba | |||||||
| 4 | B | |||||||
| 5 | Caa | |||||||
| 6 | Ca and lower | |||||||
For most of the bonds held in our portfolio the NAIC designation matches the NRSRO equivalent rating. However, for certain loan-backed and structured securities, as defined by the NAIC, the NAIC rating is not always equivalent to the NRSRO rating presented in the previous table. The NAIC has adopted revised rating methodologies for certain loan-backed and structured securities comprised of non-agency residential mortgage backed securities ("RMBS") and commercial mortgage backed securities ("CMBS"). The NAIC’s objective with the revised rating methodologies for these structured securities is to increase the accuracy in assessing expected losses and use the improved assessment to determine a more appropriate capital requirement for such structured securities. The revised methodologies reduce regulatory reliance on rating agencies and allow for greater regulatory input into the assumptions used to estimate expected losses from structured securities.
The use of this process by the SVO may result in certain non-agency RMBS and CMBS being assigned an NAIC designation that is higher than the equivalent NRSRO rating. The NAIC designations for non-agency RMBS and CMBS are based on security level expected losses as modeled by an independent third party (engaged by the NAIC) and the statutory carrying value of the security, including any purchase discounts or impairment charges previously recognized. Evaluation of non-agency RMBS and CMBS held by insurers using the NAIC rating methodologies is performed on an annual basis.
As stated previously, our fixed maturity security portfolio is managed to minimize risks such as defaults or impairments while earning a sufficient and stable return on our investments. Our strategy has been to invest primarily in investment grade fixed maturity securities. Investment grade is NAIC 1 and 2 securities and Baa3/BBB- and better securities on the NRSRO scale. This strategy meets the objective of minimizing risk while also managing asset capital charges on a regulatory capital basis.
A summary of our fixed maturity securities by NAIC designation is as follows:
| September 30, 2020 | December 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||
| NAIC Designation | Amortized Cost | Fair Value | Carrying Amount | Percent of Total Carrying Amount | Amortized Cost | Fair Value | Carrying Amount | Percent of Total Carrying Amount | ||||||||||||||||||||||||||||||||||||||||||
| (Dollars in thousands) | (Dollars in thousands) | |||||||||||||||||||||||||||||||||||||||||||||||||
| 1 | $ | 25,857,683 | $ | 28,981,733 | $ | 28,981,733 | 56.1 | % | $ | 27,781,525 | $ | 30,122,657 | $ | 30,122,657 | 58.4 | % | ||||||||||||||||||||||||||||||||||
| 2 | 18,973,077 | 20,682,645 | 20,682,645 | 40.0 | % | 19,278,355 | 20,316,911 | 20,316,911 | 39.4 | % | ||||||||||||||||||||||||||||||||||||||||
| 3 | 1,844,263 | 1,684,689 | 1,684,689 | 3.3 | % | 1,001,087 | 977,191 | 977,191 | 1.9 | % | ||||||||||||||||||||||||||||||||||||||||
| 4 | 300,794 | 248,133 | 248,133 | 0.5 | % | 114,497 | 112,534 | 112,534 | 0.2 | % | ||||||||||||||||||||||||||||||||||||||||
| 5 | 81,869 | 80,048 | 80,048 | 0.1 | % | 57,952 | 45,205 | 45,205 | 0.1 | % | ||||||||||||||||||||||||||||||||||||||||
| 6 | 74,929 | 23,495 | 23,495 | — | % | 5,530 | 5,992 | 5,992 | — | % | ||||||||||||||||||||||||||||||||||||||||
| $ | 47,132,615 | $ | 51,700,743 | $ | 51,700,743 | 100.0 | % | $ | 48,238,946 | $ | 51,580,490 | $ | 51,580,490 | 100.0 | % | |||||||||||||||||||||||||||||||||||
The amortized cost and fair value of fixed maturity securities at September 30, 2020, by contractual maturity, are presented in Note 3 to our unaudited consolidated financial statements in this Form 10-Q, which is incorporated by reference in this Item 2.
41
Unrealized Losses
The amortized cost and fair value of fixed maturity securities that were in an unrealized loss position were as follows:
| Number of Securities | Amortized Cost | Unrealized Losses, Net of Allowance | Allowance for Credit Losses | Fair Value | |||||||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||||||||
| September 30, 2020 | |||||||||||||||||||||||||||||
| Fixed maturity securities, available for sale: | |||||||||||||||||||||||||||||
| United States Government sponsored agencies | 6 | $ | 800,682 | $ | (672) | $ | — | $ | 800,010 | ||||||||||||||||||||
| United States municipalities, states and territories | 15 | 46,036 | (5,866) | — | 40,170 | ||||||||||||||||||||||||
| Foreign government obligations | 1 | 14,190 | (408) | — | 13,782 | ||||||||||||||||||||||||
| Corporate securities: | |||||||||||||||||||||||||||||
| Finance, insurance and real estate | 30 | 337,874 | (12,818) | — | 325,056 | ||||||||||||||||||||||||
| Manufacturing, construction and mining | 19 | 160,490 | (9,919) | — | 150,571 | ||||||||||||||||||||||||
| Utilities and related sectors | 61 | 512,293 | (62,235) | (1,615) | 448,443 | ||||||||||||||||||||||||
| Wholesale/retail trade | 31 | 284,112 | (34,233) | — | 249,879 | ||||||||||||||||||||||||
| Services, media and other | 82 | 749,435 | (62,422) | (51,430) | 635,583 | ||||||||||||||||||||||||
| Residential mortgage backed securities | 51 | 225,825 | (3,767) | (1,221) | 220,837 | ||||||||||||||||||||||||
| Commercial mortgage backed securities | 309 | 2,232,993 | (202,723) | (7,353) | 2,022,917 | ||||||||||||||||||||||||
| Other asset backed securities | 739 | 4,771,176 | (348,848) | — | 4,422,328 | ||||||||||||||||||||||||
| 1,344 | $ | 10,135,106 | $ | (743,911) | $ | (61,619) | $ | 9,329,576 | |||||||||||||||||||||
| December 31, 2019 | |||||||||||||||||||||||||||||
| Fixed maturity securities, available for sale: | |||||||||||||||||||||||||||||
| United States Government full faith and credit | 5 | $ | 144,678 | $ | (96) | $ | — | $ | 144,582 | ||||||||||||||||||||
| United States Government sponsored agencies | 6 | 374,961 | (4,785) | — | 370,176 | ||||||||||||||||||||||||
| United States municipalities, states and territories | 42 | 296,812 | (8,250) | — | 288,562 | ||||||||||||||||||||||||
| Corporate securities: | |||||||||||||||||||||||||||||
| Finance, insurance and real estate | 38 | 399,043 | (9,529) | — | 389,514 | ||||||||||||||||||||||||
| Manufacturing, construction and mining | 20 | 216,229 | (9,990) | — | 206,239 | ||||||||||||||||||||||||
| Utilities and related sectors | 32 | 397,116 | (11,212) | — | 385,904 | ||||||||||||||||||||||||
| Wholesale/retail trade | 12 | 194,815 | (11,162) | — | 183,653 | ||||||||||||||||||||||||
| Services, media and other | 65 | 631,587 | (40,366) | — | 591,221 | ||||||||||||||||||||||||
| Residential mortgage backed securities | 34 | 227,427 | (3,691) | — | 223,736 | ||||||||||||||||||||||||
| Commercial mortgage backed securities | 127 | 810,505 | (13,783) | — | 796,722 | ||||||||||||||||||||||||
| Other asset backed securities | 652 | 4,306,620 | (179,191) | — | 4,127,429 | ||||||||||||||||||||||||
| 1,033 | $ | 7,999,793 | $ | (292,055) | $ | — | $ | 7,707,738 | |||||||||||||||||||||
The unrealized losses at September 30, 2020 are principally related to the impacts the COVID-19 pandemic has had on credit markets. Approximately 67% and 79% of the unrealized losses on fixed maturity securities shown in the above table for September 30, 2020 and December 31, 2019, respectively, are on securities that are rated investment grade, defined as being the highest two NAIC designations.
The increase in unrealized losses from December 31, 2019 to September 30, 2020 was primarily related to the impacts the COVID-19 pandemic had on credit markets. While treasury yields declined during the nine months ended September 30, 2020, credit spreads have widened. The widening of credit spreads in most cases was driven by a flight to quality into treasury securities due to illiquidity and uncertainty of the impact of the COVID-19 pandemic on the economy. The 10-year U.S. Treasury yields at September 30, 2020 and December 31, 2019 were 0.69% and 1.92%, respectively. The 30-year U.S. Treasury yields at September 30, 2020 and December 31, 2019 were 1.46% and 2.39%, respectively.
42
The following table sets forth the composition by credit quality (NAIC designation) of fixed maturity securities with gross unrealized losses:
| NAIC Designation | Carrying Value of Securities with Gross Unrealized Losses | Percent of Total | Gross Unrealized Losses (1) | Percent of Total | ||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||
| September 30, 2020 | ||||||||||||||||||||||||||
| 1 | $ | 4,491,450 | 48.2 | % | $ | (216,558) | 29.1 | % | ||||||||||||||||||
| 2 | 3,283,029 | 35.2 | % | (280,939) | 37.8 | % | ||||||||||||||||||||
| 3 | 1,260,783 | 13.5 | % | (181,374) | 24.4 | % | ||||||||||||||||||||
| 4 | 243,452 | 2.6 | % | (52,509) | 7.0 | % | ||||||||||||||||||||
| 5 | 28,289 | 0.3 | % | (4,495) | 0.6 | % | ||||||||||||||||||||
| 6 | 22,573 | 0.2 | % | (8,036) | 1.1 | % | ||||||||||||||||||||
| $ | 9,329,576 | 100.0 | % | $ | (743,911) | 100.0 | % | |||||||||||||||||||
| December 31, 2019 | ||||||||||||||||||||||||||
| 1 | $ | 3,580,578 | 46.4 | % | $ | (79,638) | 27.3 | % | ||||||||||||||||||
| 2 | 3,412,695 | 44.3 | % | (151,826) | 52.0 | % | ||||||||||||||||||||
| 3 | 613,240 | 8.0 | % | (38,216) | 13.1 | % | ||||||||||||||||||||
| 4 | 74,027 | 1.0 | % | (8,575) | 2.9 | % | ||||||||||||||||||||
| 5 | 26,998 | 0.3 | % | (13,437) | 4.6 | % | ||||||||||||||||||||
| 6 | 200 | — | % | (363) | 0.1 | % | ||||||||||||||||||||
| $ | 7,707,738 | 100.0 | % | $ | (292,055) | 100.0 | % | |||||||||||||||||||
(1) Gross unrealized losses have been adjusted to reflect the allowance for credit loss as of September 30, 2020 of $61.6 million.
Our investments' gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities (consisting of 1,344 and 1,033 securities, respectively) have been in a continuous unrealized loss position at September 30, 2020 and December 31, 2019, along with a description of the factors causing the unrealized losses is presented in Note 3 to our unaudited consolidated financial statements in this Form 10-Q, which is incorporated by reference in this Item 2.
43
The amortized cost and fair value of fixed maturity securities in an unrealized loss position and the number of months in a continuous unrealized loss position (fixed maturity securities that carry an NRSRO rating of BBB/Baa or higher are considered investment grade) were as follows:
| Number of Securities | Amortized Cost, Net of Allowance (1) | Fair Value | Gross Unrealized Losses, Net of Allowance (1) | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| September 30, 2020 | |||||||||||||||||||||||
| Fixed maturity securities, available for sale: | |||||||||||||||||||||||
| Investment grade: | |||||||||||||||||||||||
| Less than six months | 148 | $ | 1,754,169 | $ | 1,725,012 | $ | (29,157) | ||||||||||||||||
| Six months or more and less than twelve months | 567 | 3,982,278 | 3,713,531 | (268,747) | |||||||||||||||||||
| Twelve months or greater | 361 | 2,602,800 | 2,389,680 | (213,120) | |||||||||||||||||||
| Total investment grade | 1,076 | 8,339,247 | 7,828,223 | (511,024) | |||||||||||||||||||
| Below investment grade: | |||||||||||||||||||||||
| Less than six months | 34 | 225,537 | 200,433 | (25,104) | |||||||||||||||||||
| Six months or more and less than twelve months | 80 | 526,071 | 461,852 | (64,219) | |||||||||||||||||||
| Twelve months or greater | 154 | 982,632 | 839,068 | (143,564) | |||||||||||||||||||
| Total below investment grade | 268 | 1,734,240 | 1,501,353 | (232,887) | |||||||||||||||||||
| 1,344 | $ | 10,073,487 | $ | 9,329,576 | $ | (743,911) | |||||||||||||||||
| December 31, 2019 | |||||||||||||||||||||||
| Fixed maturity securities, available for sale: | |||||||||||||||||||||||
| Investment grade: | |||||||||||||||||||||||
| Less than six months | 352 | $ | 2,960,557 | $ | 2,911,909 | $ | (48,648) | ||||||||||||||||
| Six months or more and less than twelve months | 46 | 290,674 | 282,347 | (8,327) | |||||||||||||||||||
| Twelve months or greater | 513 | 4,003,478 | 3,829,474 | (174,004) | |||||||||||||||||||
| Total investment grade | 911 | 7,254,709 | 7,023,730 | (230,979) | |||||||||||||||||||
| Below investment grade: | |||||||||||||||||||||||
| Less than six months | 11 | 32,607 | 31,695 | (912) | |||||||||||||||||||
| Six months or more and less than twelve months | 8 | 35,080 | 33,268 | (1,812) | |||||||||||||||||||
| Twelve months or greater | 103 | 677,397 | 619,045 | (58,352) | |||||||||||||||||||
| Total below investment grade | 122 | 745,084 | 684,008 | (61,076) | |||||||||||||||||||
| 1,033 | $ | 7,999,793 | $ | 7,707,738 | $ | (292,055) | |||||||||||||||||
(1) Amortized cost and gross unrealized losses have been adjusted to reflect the allowance for credit loss as of September 30, 2020 of $61.6 million.
44
The amortized cost and fair value of fixed maturity securities (excluding United States Government and United States Government sponsored agency securities) segregated by investment grade (NRSRO rating of BBB/Baa or higher) and below investment grade that had unrealized losses greater than 20% and the number of months in a continuous unrealized loss position were as follows:
| Number of Securities | Amortized Cost, Net of Allowance (1) | Fair Value | Gross Unrealized Losses, Net of Allowance (1) | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| September 30, 2020 | |||||||||||||||||||||||
| Investment grade: | |||||||||||||||||||||||
| Less than six months | 11 | $ | 100,733 | $ | 71,823 | $ | (28,910) | ||||||||||||||||
| Six months or more and less than twelve months | 24 | 186,115 | 134,412 | (51,703) | |||||||||||||||||||
| Twelve months or greater | — | — | — | — | |||||||||||||||||||
| Total investment grade | 35 | 286,848 | 206,235 | (80,613) | |||||||||||||||||||
| Below investment grade: | |||||||||||||||||||||||
| Less than six months | 33 | 148,666 | 109,890 | (38,776) | |||||||||||||||||||
| Six months or more and less than twelve months | 23 | 173,162 | 124,873 | (48,289) | |||||||||||||||||||
| Twelve months or greater | 3 | 10,320 | 6,293 | (4,027) | |||||||||||||||||||
| Total below investment grade | 59 | 332,148 | 241,056 | (91,092) | |||||||||||||||||||
| 94 | $ | 618,996 | $ | 447,291 | $ | (171,705) | |||||||||||||||||
| December 31, 2019 | |||||||||||||||||||||||
| Investment grade: | |||||||||||||||||||||||
| Less than six months | — | $ | — | $ | — | $ | — | ||||||||||||||||
| Six months or more and less than twelve months | — | — | — | — | |||||||||||||||||||
| Twelve months or greater | — | — | — | — | |||||||||||||||||||
| Total investment grade | — | — | — | — | |||||||||||||||||||
| Below investment grade: | |||||||||||||||||||||||
| Less than six months | — | — | — | — | |||||||||||||||||||
| Six months or more and less than twelve months | 1 | 2,640 | 1,755 | (885) | |||||||||||||||||||
| Twelve months or greater | 4 | 53,800 | 35,541 | (18,259) | |||||||||||||||||||
| Total below investment grade | 5 | 56,440 | 37,296 | (19,144) | |||||||||||||||||||
| 5 | $ | 56,440 | $ | 37,296 | $ | (19,144) | |||||||||||||||||
(1) Amortized cost and gross unrealized losses have been adjusted to reflect the allowance for credit loss as of September 30, 2020 of $61.6 million.
45
The amortized cost and fair value of fixed maturity securities, by contractual maturity, that were in an unrealized loss position are shown below. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. All of our mortgage and other asset backed securities provide for periodic payments throughout their lives, and are shown below as a separate line.
| Available for sale | |||||||||||
| Amortized Cost | Fair Value | ||||||||||
| (Dollars in thousands) | |||||||||||
| September 30, 2020 | |||||||||||
| Due in one year or less | $ | 3,108 | $ | 2,228 | |||||||
| Due after one year through five years | 1,166,223 | 1,125,636 | |||||||||
| Due after five years through ten years | 871,939 | 771,026 | |||||||||
| Due after ten years through twenty years | 449,485 | 409,951 | |||||||||
| Due after twenty years | 414,357 | 354,653 | |||||||||
| 2,905,112 | 2,663,494 | ||||||||||
| Residential mortgage backed securities | 225,825 | 220,837 | |||||||||
| Commercial mortgage backed securities | 2,232,993 | 2,022,917 | |||||||||
| Other asset backed securities | 4,771,176 | 4,422,328 | |||||||||
| $ | 10,135,106 | $ | 9,329,576 | ||||||||
| December 31, 2019 | |||||||||||
| Due in one year or less | $ | 5,073 | $ | 5,071 | |||||||
| Due after one year through five years | 278,165 | 273,869 | |||||||||
| Due after five years through ten years | 555,200 | 544,687 | |||||||||
| Due after ten years through twenty years | 1,041,474 | 1,008,487 | |||||||||
| Due after twenty years | 775,329 | 727,737 | |||||||||
| 2,655,241 | 2,559,851 | ||||||||||
| Residential mortgage backed securities | 227,427 | 223,736 | |||||||||
| Commercial mortgage backed securities | 810,505 | 796,722 | |||||||||
| Other asset backed securities | 4,306,620 | 4,127,429 | |||||||||
| $ | 7,999,793 | $ | 7,707,738 | ||||||||
International Exposure
We hold fixed maturity securities with international exposure. As of September 30, 2020, 24% of the carrying value of our fixed maturity securities was comprised of corporate debt securities of issuers based outside of the United States and debt securities of foreign governments. All of our fixed maturity securities with international exposure are denominated in U.S. dollars. Our investment professionals analyze each holding for credit risk by economic and other factors of each country and industry. The following table presents our international exposure in our fixed maturity portfolio by country or region:
| September 30, 2020 | |||||||||||||||||
| Amortized Cost | Carrying Amount/ Fair Value | Percent of Total Carrying Amount | |||||||||||||||
| (Dollars in thousands) | |||||||||||||||||
| GIIPS (1) | $ | 251,563 | $ | 281,301 | 0.5 | % | |||||||||||
| Asia/Pacific | 436,613 | 499,825 | 1.0 | % | |||||||||||||
| Non-GIIPS Europe | 2,960,710 | 3,292,311 | 6.4 | % | |||||||||||||
| Latin America | 254,541 | 286,902 | 0.5 | % | |||||||||||||
| Non-U.S. North America | 1,403,319 | 1,566,323 | 3.0 | % | |||||||||||||
| Australia & New Zealand | 1,047,547 | 1,130,250 | 2.2 | % | |||||||||||||
| Other | 5,543,900 | 5,318,443 | 10.3 | % | |||||||||||||
| $ | 11,898,193 | $ | 12,375,355 | 23.9 | % | ||||||||||||
(1)Greece, Ireland, Italy, Portugal and Spain ("GIIPS"). All of our exposure in GIIPS are corporate securities with issuers domiciled in these countries. None of our foreign government obligations were held in any of these countries.
46
All of the securities presented in the table above are investment grade (NAIC designation of either 1 or 2), except for the following:
| September 30, 2020 | |||||||||||
| Amortized Cost | Carrying Amount/ Fair Value | ||||||||||
| (Dollars in thousands) | |||||||||||
| GIIPS | $ | 14,547 | $ | 17,248 | |||||||
| Asia/Pacific | 11,000 | 10,951 | |||||||||
| Non-GIIPS Europe | 223,929 | 197,189 | |||||||||
| Latin America | 74,579 | 76,354 | |||||||||
| Non-U.S. North America | 112,518 | 101,765 | |||||||||
| Other | 814,196 | 709,817 | |||||||||
| $ | 1,250,769 | $ | 1,113,324 | ||||||||
Watch List
At each balance sheet date, we identify invested assets which have characteristics (i.e., significant unrealized losses compared to amortized cost and industry trends) creating uncertainty as to our future assessment of credit losses. As part of this assessment, we review not only a change in current price relative to its amortized cost but the issuer's current credit rating and the probability of full recovery of principal based upon the issuer's financial strength. For corporate issues, we evaluate the financial stability and quality of asset coverage for the securities relative to the term to maturity for the issues we own. For asset-backed securities, we evaluate changes in factors such as collateral performance, default rates, loss severities and expected cash flows. At September 30, 2020, the amortized cost and fair value of securities on the watch list (all fixed maturity securities) are as follows:
| General Description | Number of Securities | Amortized Cost | Allowance for Credit Losses | Amortized Cost, Net of Allowance | Net Unrealized Losses, Net of Allowance | Fair Value | ||||||||||||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
| Corporate securities - Public securities | 17 | $ | 202,148 | $ | (51,430) | $ | 150,718 | $ | (23,736) | $ | 126,982 | |||||||||||||||||||||||||||
| Corporate securities - Private placement securities | 35 | 350,537 | (1,615) | 348,922 | (22,957) | 325,965 | ||||||||||||||||||||||||||||||||
| Residential mortgage backed securities | 21 | 59,491 | (1,221) | 58,270 | (501) | 57,769 | ||||||||||||||||||||||||||||||||
| Commercial mortgage backed securities | 24 | 250,545 | (7,353) | 243,192 | (47,711) | 195,481 | ||||||||||||||||||||||||||||||||
| Other asset backed securities | 2 | 69,738 | — | 69,738 | (8,780) | 60,958 | ||||||||||||||||||||||||||||||||
| Collateralized loan obligations | 8 | 74,805 | — | 74,805 | (14,081) | 60,724 | ||||||||||||||||||||||||||||||||
| 107 | $ | 1,007,264 | $ | (61,619) | $ | 945,645 | $ | (117,766) | $ | 827,879 | ||||||||||||||||||||||||||||
We expect to recover the unrealized losses, net of allowances, as we did not have the intent to sell and it was not more likely than not that we would be required to sell these securities prior to recovery of the amortized cost basis, net of allowances. Our analysis of these securities and their credit performance at September 30, 2020 is as follows:
Corporate securities - public securities: The public corporate securities included on the watch list are primarily domestic oil drillers or securities with exposure to the travel industry. The decline in value of the securities of domestic oil drillers is due to the continuing low level of oil prices, which has caused credit metrics to continue to be under pressure. The decline in value and the heightened credit risk on the securities with exposure to the travel industry is primarily due to the impact COVID-19 has had on the travel industry As a result of our process for identifying securities that could potentially have credit losses, we recognized credit losses of $4.8 million and $51.5 million, respectively, on these securities during the three and nine months ended September 30, 2020.
Corporate securities - private placement securities: The private placement securities included on the watch list are spread across numerous industries, the most significant of which is the airlines industry. The heightened credit risk on these securities is primarily due to the impact COVID-19 has had on the travel industry. While there is a heightened level of credit risk for the private placement securities included on the watch list, we expect minimal credit losses on these securities based on our current analyses. Based on these analyses, we recognized credit losses of $1.5 million and $1.6 million, respectively, on these securities during the three and nine months ended September 30, 2020.
Residential mortgage backed securities: The residential mortgage backed securities included on the watch list have generally experienced higher levels of stress due to the impact COVID-19 is having on the economy. While there is a heightened level of credit risk for the residential mortgage backed securities included on the watch list, we expect minimal credit losses on these securities based on our current analyses. Based on these analyses, we recognized credit losses of $0.4 million and $1.2 million, respectively, on these securities during the three and nine months ended September 30, 2020.
47
Commercial mortgage backed securities: The commercial mortgage backed securities included on the watch list have generally experienced higher levels of stress due to the impact COVID-19 is having on the economy. As a result of our process for identifying securities that could potentially have credit losses and our intent to sell certain commercial mortgage backed securities, we recognized credit losses of $19.2 million and $27.5 million, respectively, on these securities during the three and nine months ended September 30, 2020.
Other asset backed securities: The decline in value of these securities, which are primarily related to the auto rental industry, is primarily a result of the impact COVID-19 has had on the travel industry. We did not take any credit losses on these securities during the three or nine months ended September 30, 2020 as we do not expect any credit losses on the securities based on our current analyses. We recognized a credit loss of $0.5 million on an other asset backed security during the nine months ended September 30, 2020 due to our intent to sell the security.
Collateralized loan obligations: The collateralized loan obligations included on the watch list have generally experienced higher levels of stress due to the impact COVID-19 is having on the economy. While there is a heightened level of credit risk for the collateralized loan obligations included on the watch list, we do not expect credit losses on these securities based on our current analyses.
Credit Losses
We have a policy and process to identify securities in our investment portfolio for which we recognize credit loss. See Note 3 to our unaudited consolidated financial statements.
During the three and nine months ended September 30, 2020, we recognized credit losses of $4.8 million and $51.5 million, respectively, on corporate securities with exposure to the offshore drilling industry as discussed above and $19.2 million and $27.5 million, respectively, on commercial mortgage backed securities due to the impact of COVID-19 on the performance of the underlying collateral or our intent to sell the securities. In addition, during the three and nine months ended September 30, 2020, we recognized credit losses of $0.4 million and $1.2 million, respectively, on residential mortgage backed securities due to the performance of the underlying collateral and $1.5 million and $1.6 million, respectively, on private placement securities with exposure primarily to the airlines industry. During the nine months ended September 30, 2020 we recognized a credit loss of $0.5 million on an asset backed security due to our intent to sell such security.
Several factors led us to believe that full recovery of amortized cost is not expected on the securities for which we recognized credit losses. A discussion of these factors, our policy and process to identify securities that could potentially have credit loss is presented in Note 3 to our unaudited consolidated financial statements in this Form 10-Q, which is incorporated by reference in this Item 2.
Mortgage Loans on Real Estate
Our financing receivables consist of two mortgage loan portfolio segments: commercial mortgage loans and residential mortgage loans. Our commercial mortgage loan portfolio consists of mortgage loans collateralized by the related properties and diversified as to property type, location and loan size. Our mortgage lending policies establish limits on the amount that can be loaned to one borrower and other criteria to attempt to reduce the risk of default. Our residential mortgage loan portfolio consists of loans with an outstanding principal balance of $171.9 million that have been purchased throughout 2020. These loans are collateralized by the related properties and diversified as to location within the United States. Mortgage loans on real estate are generally reported at cost adjusted for amortization of premiums and accrual of discounts, computed using the interest method and net of valuation allowances.
At September 30, 2020 and December 31, 2019, the largest principal amount outstanding for any single commercial mortgage loan was $34.7 million and $28.5 million, respectively, and the average loan size was $4.7 million and $4.4 million, respectively. In addition, the average loan to value ratio for commercial mortgage loans was 53.9% and 54.3% at September 30, 2020 and December 31, 2019, respectively, based upon the underwriting and appraisal at the time the loan was made. This loan to value is indicative of our conservative underwriting policies and practices for making commercial mortgage loans and may not be indicative of collateral values at the current reporting date. Our current practice is to only obtain market value appraisals of the underlying collateral at the inception of the loan unless we identify indicators of impairment in our ongoing analysis of the portfolio, in which case, we either calculate a value of the collateral using a capitalization method or obtain a third party appraisal of the underlying collateral. The commercial mortgage loan portfolio is summarized by geographic region and property type in Note 4 to our unaudited consolidated financial statements in this Form 10-Q, incorporated by reference in this Item 2.
In the normal course of business, we commit to fund commercial mortgage loans up to 90 days in advance. At September 30, 2020, we had commitments to fund commercial mortgage loans totaling $106.1 million, with interest rates ranging from 3.00% to 5.65%. During 2020 and 2019, due to historically low interest rates, the commercial mortgage loan industry has been very competitive. This competition has resulted in a number of borrowers refinancing with other lenders. For the nine months ended September 30, 2020, we received $126.4 million in cash for loans being paid in full compared to $127.5 million for the nine months ended September 30, 2019. Some of the loans being paid off have either reached their maturity or are nearing maturity; however, some borrowers are paying the prepayment fee and refinancing at a lower rate.
See Note 4 to our unaudited consolidated financial statements, incorporated by reference, for a presentation of our valuation allowance, foreclosure activity and troubled debt restructure analysis. We have a process by which we evaluate the credit quality of each of our commercial mortgage loans. This process utilizes each loan's loan-to-value and debt service coverage ratios as primary metrics. See Note 4 to our unaudited consolidated financial statements, incorporated by reference, for a summary of our portfolio by loan-to-value and debt service coverage ratios.
48
We closely monitor loan performance for both our commercial and residential mortgage loan portfolios. Commercial and residential loans are considered nonperforming when they are 90 days or more past due. Aging of financing receivables is summarized in the following table:
| Current | 30-59 days past due | 60-89 days past due | Over 90 days past due | Total | |||||||||||||||||||||||||
| As of September 30, 2020: | (Dollars in thousands) | ||||||||||||||||||||||||||||
| Commercial mortgage loans | $ | 3,776,490 | $ | — | $ | — | $ | — | $ | 3,776,490 | |||||||||||||||||||
| Residential mortgage loans | 166,171 | 2,546 | 771 | — | 169,488 | ||||||||||||||||||||||||
| Total mortgage loans | $ | 3,942,661 | $ | 2,546 | $ | 771 | $ | — | $ | 3,945,978 | |||||||||||||||||||
Derivative Instruments
Our derivative instruments primarily consist of call options purchased to provide the income needed to fund the annual index credits on our fixed index annuity products. The fair value of the call options is based upon the amount of cash that would be required to settle the call options obtained from the counterparties adjusted for the nonperformance risk of the counterparty. The nonperformance risk for each counterparty is based upon its credit default swap rate. We have no performance obligations related to the call options.
None of our derivatives qualify for hedge accounting, thus, any change in the fair value of the derivatives is recognized immediately in the consolidated statements of operations. A presentation of our derivative instruments along with a discussion of the business strategy involved with our derivatives is included in Note 5 to our unaudited consolidated financial statements in this Form 10-Q, which is incorporated by reference in this Item 2.
Liquidity and Capital Resources
Our insurance subsidiaries generally have adequate cash flows from annuity deposits and investment income to meet their policyholder and other obligations. Net cash flows from annuity deposits and funds returned to policyholders as surrenders, withdrawals and death claims were $(806) million for the nine months ended September 30, 2020 compared to $1.5 billion for the nine months ended September 30, 2019, with the decrease attributable to a $2.0 billion decrease in net annuity deposits after coinsurance and a $243 million (after coinsurance) increase in funds returned to policyholders. As a result of funds returned to policyholders being in excess of cash flows from annuity deposits for the nine months ended September 30, 2020, we experienced a net cash outflow related to policyholder activity which was funded primarily by cash flows from investment income. We may continue to experience net cash outflows related to policyholder activity due to lower sales as a result of social distancing due to COVID-19. We continue to invest the net proceeds from policyholder transactions and investment activities in high quality fixed maturity securities and mortgage loans.
We, as the parent company, are a legal entity separate and distinct from our subsidiaries, and have no business operations. We need liquidity primarily to service our debt (senior notes and subordinated debentures issued to subsidiary trusts), pay operating expenses and pay dividends to common and preferred stockholders. Our assets consist primarily of the capital stock and surplus notes of our subsidiaries. Accordingly, our future cash flows depend upon the availability of dividends, surplus note interest payments and other statutorily permissible payments from our subsidiaries, such as payments under our investment advisory agreements and tax allocation agreement with our subsidiaries. These sources provide adequate cash flow for us to meet our current and reasonably foreseeable future obligations.
The ability of our life insurance subsidiaries to pay dividends or distributions, including surplus note payments, will be limited by applicable laws and regulations of the states in which our life insurance subsidiaries are domiciled, which subject our life insurance subsidiaries to significant regulatory restrictions. These laws and regulations require, among other things, our insurance subsidiaries to maintain minimum solvency requirements and limit the amount of dividends these subsidiaries can pay.
Currently, American Equity Investment Life Insurance Company ("American Equity Life") may pay dividends or make other distributions without the prior approval of the Iowa Insurance Commissioner, unless such payments, together with all other such payments within the preceding twelve months, exceed the greater of (1) American Equity Life's net gain from operations for the preceding calendar year, or (2) 10% of American Equity Life's statutory capital and surplus at the preceding December 31. For 2020, up to $349.0 million can be distributed as dividends by American Equity Life without prior approval of the Iowa Insurance Commissioner. In addition, dividends and surplus note payments may be made only out of statutory earned surplus, and all surplus note payments are subject to prior approval by regulatory authorities in the life subsidiary's state of domicile. American Equity Life had $2.1 billion of statutory earned surplus at September 30, 2020.
The maximum distribution permitted by law or contract is not necessarily indicative of an insurer's actual ability to pay such distributions, which may be constrained by business and regulatory considerations, such as the impact of such distributions on surplus, which could affect the insurer's ratings or competitive position, the amount of premiums that can be written and the ability to pay future dividends or make other distributions. Further, state insurance laws and regulations require that the statutory surplus of our life subsidiaries following any dividend or distribution must be reasonable in relation to their outstanding liabilities and adequate for their financial needs. Along with solvency regulations, the primary driver in determining the amount of capital used for dividends is the level of capital needed to maintain desired financial strength ratings from rating agencies. Both regulators and rating agencies could become more conservative in their methodology and criteria, including increasing capital requirements for our insurance subsidiaries which, in turn, could negatively affect the cash available to us from insurance subsidiaries. As of September 30, 2020, we estimate American Equity Life has sufficient statutory capital and surplus, combined with capital available to the holding company, to maintain this rating objective. However, this capital may not be sufficient if significant future losses are incurred or a rating agency modifies its rating criteria and access to additional capital could be limited.
49
The transfer of funds by American Equity Life is also restricted by a covenant in our line of credit agreement which requires American Equity Life to maintain a minimum RBC ratio of 275% and a minimum level of statutory surplus equal to the sum of 1) 80% of statutory surplus at June 30, 2016, 2) 50% of the statutory net income for each fiscal quarter ending after June 30, 2016, and 3) 50% of all capital contributed to American Equity Life after June 30, 2016. American Equity Life's RBC ratio was 372% at December 31, 2019. Under this agreement, we are also required to maintain a maximum ratio of adjusted debt to total adjusted capital of 0.35.
On June 10, 2020, we issued 12,000 shares of 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B ("Series B") with a $1.00 par value per share and a liquidation preference of $25,000 per share, for aggregate net proceeds of $290.3 million.
On November 21, 2019 we issued $400 million of 5.95% fixed-rate reset non-cumulative preferred stock and received net proceeds of $388.9 million. We used a portion of the proceeds to redeem $165 million of our floating rate subordinated debentures in the fourth quarter of 2019 and the first quarter of 2020 and contributed $200 million to American Equity Life during May of 2020.
Cash and cash equivalents of the parent holding company at September 30, 2020, were $353.4 million which includes the $290.3 million of net proceeds from the Series B preferred issuance described above. In addition, we have a $150 million revolving line of credit, with no borrowings outstanding, available through September 2021 for general corporate purposes of the parent company and its subsidiaries. We also have the ability to issue equity, debt or other types of securities through one or more methods of distribution. The terms of any offering would be established at the time of the offering, subject to market conditions.
New Accounting Pronouncements
See Note 1 to our unaudited consolidated financial statements in this Form 10-Q, which is incorporated by reference in this Item 2.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We seek to invest our available funds in a manner that will maximize shareholder value and fund future obligations to policyholders and debtors, subject to appropriate risk considerations. We seek to meet this objective through investments that: (i) consist substantially of investment grade fixed maturity securities, (ii) have projected returns which satisfy our spread targets, and (iii) have characteristics which support the underlying liabilities. Many of our products incorporate surrender charges, market interest rate adjustments or other features, including lifetime income benefit riders, to encourage persistency.
We seek to maximize the total return on our fixed maturity securities through active investment management. Accordingly, we have determined that our available for sale portfolio of fixed maturity securities is available to be sold in response to: (i) changes in market interest rates, (ii) changes in relative values of individual securities and asset sectors, (iii) changes in prepayment risks, (iv) changes in credit quality outlook for certain securities, (v) liquidity needs, and (vi) other factors.
Interest rate risk is our primary market risk exposure. Substantial and sustained increases and decreases in market interest rates can affect the profitability of our products and the fair value of our investments. The profitability of most of our products depends on the spreads between interest yield on investments and rates credited on insurance liabilities. We have the ability to adjust crediting rates (caps, participation rates or asset fee rates for fixed index annuities) on substantially all of our annuity liabilities at least annually (subject to minimum guaranteed values). Substantially all of our annuity products have surrender and withdrawal penalty provisions designed to encourage persistency and to help ensure targeted spreads are earned. In addition, a significant amount of our fixed index annuity policies and many of our annual reset fixed rate deferred annuities were issued with a lifetime income benefit rider which we believe improves the persistency of such annuity products. However, competitive factors, including the impact of the level of surrenders and withdrawals, may limit our ability to adjust or maintain crediting rates at levels necessary to avoid narrowing of spreads under certain market conditions.
A major component of our interest rate risk management program is structuring the investment portfolio with cash flow characteristics consistent with the cash flow characteristics of our insurance liabilities. We use models to simulate cash flows expected from our existing business under various interest rate scenarios. These simulations enable us to measure the potential gain or loss in fair value of our interest rate-sensitive financial instruments, to evaluate the adequacy of expected cash flows from our assets to meet the expected cash requirements of our liabilities and to determine if it is necessary to lengthen or shorten the average life and duration of our investment portfolio. The "duration" of a security is the time weighted present value of the security's expected cash flows and is used to measure a security's sensitivity to changes in interest rates. When the durations of assets and liabilities are similar, exposure to interest rate risk is minimized because a change in value of assets should be largely offset by a change in the value of liabilities.
50
If interest rates were to increase 10% (15 basis points) from levels at September 30, 2020, we estimate that the fair value of our fixed maturity securities would decrease by approximately $545.5 million. The impact on stockholders' equity of such decrease (net of income taxes and certain adjustments for changes in amortization of deferred policy acquisition costs and deferred sales inducements) would be a decrease of $258.9 million in accumulated other comprehensive income and a decrease in stockholders' equity. The models used to estimate the impact of a 10% change in market interest rates incorporate numerous assumptions, require significant estimates and assume an immediate and parallel change in interest rates without any management of the investment portfolio in reaction to such change. Consequently, potential changes in value of our financial instruments indicated by the simulations will likely be different from the actual changes experienced under given interest rate scenarios, and the differences may be material. Because we actively manage our investments and liabilities, our net exposure to interest rates can vary over time. However, any such decreases in the fair value of our fixed maturity securities (unless related to credit concerns of the issuer requiring recognition of a credit loss) would generally be realized only if we were required to sell such securities at losses prior to their maturity to meet our liquidity needs, which we manage using the surrender and withdrawal provisions of our annuity contracts and through other means. See Financial Condition - Liquidity for Insurance Operations included in Management's Discussion and Analysis in our Annual Report on Form 10-K for the year ended December 31, 2019 for a further discussion of liquidity risk.
The amortized cost of fixed maturity securities that are callable at the option of the issuer, excluding securities with a make-whole provision, was $7.2 billion as of September 30, 2020. We have reinvestment risk related to these redemptions to the extent we cannot reinvest the net proceeds in assets with credit quality and yield characteristics similar to the redeemed bonds. Such reinvestment risk typically occurs in a declining rate environment. In addition, we have $4.9 billion of floating rate fixed maturity securities as of September 30, 2020. Generally, interest rates on these floating rate fixed maturity securities are based on the 3 month LIBOR rate and are reset quarterly. Should rates decline to levels which tighten the spread between our average portfolio yield and average cost of interest credited on annuity liabilities, we have the ability to reduce crediting rates (caps, participation rates or asset fees for fixed index annuities) on most of our annuity liabilities to maintain the spread at our targeted level. At September 30, 2020, approximately 99% of our annuity liabilities were subject to annual adjustment of the applicable crediting rates at our discretion, limited by minimum guaranteed crediting rates specified in the policies. At September 30, 2020, approximately 19% of our annuity liabilities were at minimum guaranteed crediting rates.
We purchase call options on the applicable indices to fund the annual index credits on our fixed index annuities. These options are primarily one-year instruments purchased to match the funding requirements of the underlying policies. Fair value changes associated with those investments are substantially offset by an increase or decrease in the amounts added to policyholder account balances for fixed index products. The difference between proceeds received at expiration of these options and index credits, as shown in the following table, is primarily due to under or over-hedging as a result of policyholder behavior being different than our expectations.
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||
| Proceeds received at expiration of options related to such credits | $ | 178,405 | $ | 95,491 | $ | 560,683 | $ | 320,381 | |||||||||||||||
| Annual index credits to policyholders on their anniversaries | 174,747 | 92,343 | 551,562 | 310,020 | |||||||||||||||||||
On the anniversary dates of the index policies, we purchase new one-year call options to fund the next annual index credits. The risk associated with these prospective purchases is the uncertainty of the cost, which will determine whether we are able to earn our spread on our fixed index business. We manage this risk through the terms of our fixed index annuities, which permit us to change caps, participation rates and asset fees, subject to contractual features. By modifying caps, participation rates or asset fees, we can limit option costs to budgeted amounts, except in cases where the contractual features would prevent further modifications. Based upon actuarial testing which we conduct as a part of the design of our fixed index products and on an ongoing basis, we believe the risk that contractual features would prevent us from controlling option costs is not material.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
In accordance with the Securities Exchange Act Rules 13a-15(e) and 15d-15(e), our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded the design and operation of our disclosure controls and procedures were effective as of September 30, 2020 in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports that we file or submit under the Exchange Act.
There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
See Note 7 - Commitments and Contingencies to the unaudited consolidated financial statements in this Form 10-Q, which is incorporated by reference in this Item 1, for litigation and regulatory disclosures.
51
Item 1A. Risk Factors
Our 2019 Annual Report on Form 10-K described our Risk Factors. We added the risk factor titled Major public health issues, specifically the COVID-19 pandemic, and the resulting economic uncertainty, may adversely impact our business, financial condition and results of operations in our Form 10-Q for the quarterly period ended March 31, 2020.
In addition, the risk factor from our 2019 Annual Report on Form 10-K titled Changes in state and federal laws and regulation may adversely affect our business, financial condition, results of operations and cash flows was revised in our Form 10-Q for the quarterly period ended June 30, 2020 to reflect the Department of Labor issuing a proposed new fiduciary regulation on June 29, 2020 related to the provision of investment advice in retirement accounts. There have been no other material changes to the Risk Factors during the nine months ended September 30, 2020.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Securities
The following table presents the amount of our share purchase activity for the periods indicated:
| Period | Total Number of Shares Purchased (a) | Average Price Paid Per Share | ||||||||||||
| January 1, 2020 - January 31, 2020 | 357 | $ | 29.89 | |||||||||||
| February 1, 2020 - February 29, 2020 | — | $ | — | |||||||||||
| March 1, 2020 - March 31, 2020 | 10,169 | $ | 18.70 | |||||||||||
| April 1, 2020 - April 30, 2020 | — | $ | — | |||||||||||
| May 1, 2020 - May 31, 2020 | — | $ | — | |||||||||||
| June 1, 2020 - June 30, 2020 | 234 | $ | 24.68 | |||||||||||
| July 1, 2020 - July 31, 2020 | — | $ | — | |||||||||||
| August 1, 2020 - August 31, 2020 | — | $ | — | |||||||||||
| September 1, 2020 - September 30, 2020 | — | $ | — | |||||||||||
| Total | 10,760 | |||||||||||||
(a)Includes the number of shares of common stock utilized to execute certain stock incentive awards.
52
Item 6. Exhibits
| Exhibit Number | Description | |||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 32.2 | ||||||||
| 101 | The following materials from American Equity Investment Life Holding Company's Quarterly Report on Form 10-Q for the period ended September 30, 2020 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Changes in Stockholders' Equity, (v) the Consolidated Statements of Cash Flows and (vi) the Notes to Unaudited Consolidated Financial Statements. | |||||||
| 104 | The cover page from American Equity Investment Life Holding Company's Quarterly Report on Form 10-Q for the period ended September 30, 2020 formatted in iXBRL and contained in Exhibit 101. | |||||||
53
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Date: | November 6, 2020 | AMERICAN EQUITY INVESTMENT LIFE | |||||||||||||||
| HOLDING COMPANY | |||||||||||||||||
| By: | /s/ Ted M. Johnson | ||||||||||||||||
| Ted M. Johnson, Chief Financial Officer and Treasurer | |||||||||||||||||
| (Principal Financial Officer and Duly Authorized Officer) | |||||||||||||||||
| By: | /s/ Scott A. Samuelson | ||||||||||||||||
| Scott A. Samuelson, Vice President and Chief Accounting Officer | |||||||||||||||||
| (Principal Accounting Officer) | |||||||||||||||||
54